<SEC-DOCUMENT>0000898822-24-000003.txt : 20240620
<SEC-HEADER>0000898822-24-000003.hdr.sgml : 20240620
<ACCEPTANCE-DATETIME>20240620171522
ACCESSION NUMBER:		0000898822-24-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240617
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240620
DATE AS OF CHANGE:		20240620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEGNA INC
		CENTRAL INDEX KEY:			0000039899
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEVISION BROADCASTING STATIONS [4833]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				160442930
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-06961
		FILM NUMBER:		241057453

	BUSINESS ADDRESS:	
		STREET 1:		8350 BROAD STREET
		STREET 2:		SUITE 2000
		CITY:			TYSONS
		STATE:			VA
		ZIP:			22102-5151
		BUSINESS PHONE:		7038736600

	MAIL ADDRESS:	
		STREET 1:		8350 BROAD STREET
		STREET 2:		SUITE 2000
		CITY:			TYSONS
		STATE:			VA
		ZIP:			22102-5151

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GANNETT CO INC /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tgna8k61924.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:tgna="http://tegna.com/20240617" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Wachtell Lipton Rosen & Katz
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_95c5785cf8274231bcc5b934ec170bc8" contextRef="c20240617to20240617" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_508c478a996c4f8aa3446ee8aa1b0652" contextRef="c20240617to20240617">0000039899</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="tgna-20240617.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20240617to20240617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000039899</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-17</xbrli:startDate><xbrli:endDate>2024-06-17</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

    <div>
      <div style="text-align: center; margin-top: 5.75pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 18pt; font-family: 'Times New Roman', Times, serif;">UNITED STATES</span><span style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><br/>
        </span><span style="font-size: 18pt; font-family: 'Times New Roman', Times, serif;">SECURITIES AND EXCHANGE COMMISSION</span><span style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><br/>
        </span>WASHINGTON, D.C. 20549</div>

    </div>

    <div>
      <div>
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    </div>

    <div>
      <div style="text-align: center; margin-top: 10pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_fb96e28f72374e1ab7ae97f11f073f23" contextRef="c20240617to20240617">8-K</ix:nonNumeric></div>

      <div>
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    </div>

    <div>
      <div style="text-align: center; margin-top: 9pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">CURRENT REPORT</div>

    </div>

    <div>
      <div style="text-align: center; margin-top: 9pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div>
              <div style="text-align: center; margin-right: 2.15pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_0f10313e758f4117926cd9eb2a114d94" contextRef="c20240617to20240617" format="ixt:date-monthname-day-year-en">June 17, 2024</ix:nonNumeric></div>
            </div>
          </td>

  </tr>


</table>
    <div>
      <div>
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 6.6667px auto; height: 1px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    </div>

    <div>
      <div style="text-align: center; margin-top: 5pt; font-family: 'Times New Roman', Times, serif; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_506a9dcd93164215bc095a9ec82ccab0" contextRef="c20240617to20240617">TEGNA INC.</ix:nonNumeric><br/>
      </div>

    </div>

    <div style="font-size: 7.5pt;">
      <div style="text-align: center; margin-top: 3pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">(Exact name of Registrant as Specified in Its Charter)</div>

      <div style="text-align: center; margin-top: 3pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 1px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/> </div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td colspan="3" style="width: 40.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_a964d12c33624433861ca12bd88eb027" contextRef="c20240617to20240617" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </div>
          </td>

    <td style="width: 18%; vertical-align: top;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_dc834b54e9364eccb647ab11db7ec86b" contextRef="c20240617to20240617">1-6961</ix:nonNumeric><br/>
              </div>
            </div>
          </td>

    <td colspan="2" style="width: 41.01%; vertical-align: top;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_7d7fd247edaa4e749176eb55a25f1104" contextRef="c20240617to20240617">16-0442930</ix:nonNumeric><br/>
              </div>
            </div>
          </td>

  </tr>

  <tr>

    <td colspan="3" style="width: 40.99%; vertical-align: top; font-size: 7.5pt;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">(State or Other Jurisdiction<span style="font-family: 'Times New Roman',Times,serif;"><br/>
                </span>of Incorporation)</div>
            </div>
          </td>

    <td colspan="2" style="width: 19.58%; vertical-align: top;">
            <div style="font-size: 7.5pt;">
              <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">(Commission File Number)</div>
            </div>
          </td>

    <td style="width: 39.43%; vertical-align: top;">
            <div style="font-size: 7.5pt;">
              <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">(IRS Employer<span style="font-family: 'Times New Roman',Times,serif;"><br/>
                </span>Identification No.)</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 19.99%; vertical-align: top;">&#160;</td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 20%; vertical-align: top;">&#160;</td>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="width: 41.01%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td colspan="3" style="width: 40.99%; vertical-align: top;">
            <div style="text-align: center;"><br/>
              <span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_3db680a68c244561bad626520b47b8a3" contextRef="c20240617to20240617">8350 Broad Street, Suite 2000</ix:nonNumeric></span></div>
          </td>

    <td colspan="3" style="width: 59.01%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td colspan="3" style="width: 40.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_f22d7b9e66264d5db43c258c97c97ca5" contextRef="c20240617to20240617">Tysons</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_d959b2d206e4494cb17483c558e04fbd" contextRef="c20240617to20240617" format="ixt-sec:stateprovnameen">Virginia</ix:nonNumeric></div>
            </div>
          </td>

    <td style="width: 18%; vertical-align: top;">&#160;</td>

    <td colspan="2" style="width: 41.01%; vertical-align: bottom;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_9a6cf583069e49c3b024b60a3edaed39" contextRef="c20240617to20240617">22102-5151</ix:nonNumeric><br/>
              </div>
            </div>
          </td>

  </tr>

  <tr>

    <td colspan="3" style="width: 40.99%; vertical-align: top;">
            <div style="font-size: 7.5pt;">
              <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">(Address of Principal Executive Offices)</div>
            </div>
          </td>

    <td style="width: 18%; vertical-align: top; font-size: 7.5pt;">&#160;</td>

    <td colspan="2" style="width: 41.01%; vertical-align: top;">
            <div style="font-size: 7.5pt;">
              <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">(Zip Code)</div>
            </div>
          </td>

  </tr>


</table>
    <div>
      <div><br/>
      </div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div>
              <div style="text-align: center; margin-right: 2.15pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Registrant&#8217;s Telephone
                  Number, Including Area Code:</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_d7828581d4b14aac891f6d9fd231cf71" contextRef="c20240617to20240617">703</ix:nonNumeric>)</span>
                <span style="font-weight: bold;"><ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_6e41d238108549b8b82a844f213c5feb" contextRef="c20240617to20240617">873-6600</ix:nonNumeric></span></div>
            </div>
          </td>

  </tr>


</table>
    <div>
      <div><br/>
      </div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 100%; vertical-align: top;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Not Applicable</div>
            </div>
          </td>

  </tr>


</table>
    <div style="font-size: 7.5pt;">
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

    </div>

    <div>
      <div>
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 6.6667px auto; height: 1px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    </div>

    <div>
      <div style="text-align: left; margin-top: 9.35pt; margin-bottom: 6pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation
        of the registrant under any of the following provisions:</div>

    </div>

    <div>
      <div style="text-align: left; text-indent: -24.5pt; margin-left: 24.5pt; margin-top: 9pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_cb0989957ef244f681a2225b165dd82f" contextRef="c20240617to20240617" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>

    </div>

    <div>
      <div style="text-align: left; text-indent: -24.5pt; margin-left: 24.5pt; margin-top: 6pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_175ca9522f61446b9444049b1f05b723" contextRef="c20240617to20240617" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>

      <div style="text-align: left; text-indent: -24.5pt; margin-left: 24.5pt; margin-top: 6pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c982b475933243cab0c063dc3e59102f" contextRef="c20240617to20240617" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>

      <div style="text-align: left; text-indent: -24.5pt; margin-left: 24.5pt; margin-top: 6pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_8359b8563a69480d83b00829a8811315" contextRef="c20240617to20240617" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>

    </div>

    <div>
      <div style="text-align: center; margin-top: 9pt; margin-bottom: 9pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Securities registered pursuant to Section 12(b) of the Act:</div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 38%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br/>
                </span>Title of each class</div>
            </div>
          </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Trading<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br/>
                </span>Symbol(s)</div>
            </div>
          </td>

    <td style="width: 1%; vertical-align: top; padding-bottom: 2px;">&#160;</td>

    <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br/>
                </span>Name of each exchange on which registered</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 38%; vertical-align: top;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_5e31ceded3774c8ba23649732e379acc" contextRef="c20240617to20240617">Common Stock, par value $1.00 per share</ix:nonNumeric><br/>
              </div>
            </div>
          </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 15%; vertical-align: top;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_2064d799a15548589e1f3ad9e109b0f3" contextRef="c20240617to20240617">TGNA</ix:nonNumeric><br/>
              </div>
            </div>
          </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_b0354103396f4afd9b37dc1aefd24d20" contextRef="c20240617to20240617">NYSE</ix:nonNumeric><br/>
              </div>
            </div>
          </td>

  </tr>


</table>
    <div>
      <div style="text-align: left; margin-top: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
        (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</div>

    </div>

    <div>
      <div style="text-align: left; margin-top: 9pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_5bda2c56866e4d05b8328b57e94400d1" contextRef="c20240617to20240617" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></div>

      <div style="text-align: left; margin-top: 9pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">If an emerging growth company, indicate by check mark if the
          registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div>

    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">


  <tr>

    <td style="width: 10%; text-align: left; vertical-align: top;"><span style="font-weight: bold;">Item 5.02.</span><br/>
              </td>

    <td style="width: 90%; text-align: left; vertical-align: bottom;">
                <div><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain</span></div>
                <div><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Officers; Compensatory Arrangements of Certain Officers.</span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;"> <br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Executive Transition and Board Appointments</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 17, 2024, TEGNA Inc. (the &#8220;Company&#8221;) announced that its Board of Directors (the &#8220;Board&#8221;) has appointed Michael Steib as President
        and Chief Executive Officer and as a member of the Board, effective as of August 12, 2024 (the &#8220;Transition Date&#8221;).&#160; Mr. Steib succeeds David T. Lougee, who will retire as President and Chief Executive Officer of the Company and resign as a member
        of the Board, in each case, effective as of the Transition Date.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mr. Steib, 47, has been the Chief Executive Officer and a member of the board of directors of Art.sy, Inc. (doing business as Artsy), an
        online art marketplace, since July 2019.&#160; From July 2013 to January 2019, Mr. Steib served as President and Chief Executive Officer of XO Group, parent company of The Knot.&#160; Prior to that, Mr. Steib served as the Chief Executive Officer of
        vente-privee devient Veepee from July 2011 to March 2013, held various executive positions at Google Inc. (now Alphabet Inc (NASDAQ: GOOG)) from January 2007 to July 2011, and held various executive positions at NBCUniversal from April 2001 to
        January 2007.&#160; Mr. Steib served as a member of the board of directors of Ally Financial Inc. (NYSE: ALLY) from July 2015 to March 2024.&#160; He is a published author and podcast host on leadership and professional development, and holds B.A. degrees in
        economics and international relations from the University of Pennsylvania.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Also on June 17, 2024, the Company announced that, effective as of July 1, 2024, the Board increased the size of the Board from nine to
        eleven directors and appointed each of Catherine Dunleavy and Denmark West to the Board, to serve until the Company&#8217;s 2025 annual meeting of stockholders.&#160; The Board has affirmatively determined that Ms. Dunleavy and Mr. West are &#8220;independent&#8221;
        under the rules of the New York Stock Exchange.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ms. Dunleavy and Mr. West will receive compensation for their service on the Board in accordance with the Company&#8217;s standard compensatory
        arrangements for non-employee directors.&#160; A description of the compensatory arrangements for non-employee directors is included in the Company&#8217;s proxy statement on Schedule 14A for its 2024 annual meeting of stockholders, which was filed with the
        U.S. Securities and Exchange Commission on March 11, 2024.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">There are no arrangements or understandings between Ms. Dunleavy or Mr. West and any other person pursuant to which Ms. Dunleavy or Mr.
        West was selected to serve as a director of the Company. Neither Ms. Dunleavy or Mr. West nor any of their respective related persons (as defined in Item 404(a) of Regulation S-K under the U.S. Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;))
        is a party to any transaction in which the Company is a participant that is required to be disclosed under Item 404(a) of Regulation S-K under the Exchange Act.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Offer Letter with Mr. Steib</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 17, 2024, the Company and Mr. Steib entered into an offer letter pursuant to which Mr. Steib&#8217;s annual base salary is $1,000,000
        and his target annual bonus opportunity is 150% of his annual base salary.&#160; Mr. Steib&#8217;s annual bonus for 2024 will be paid at the target level and prorated based on the number of days he is employed by the Company in 2024.&#160; In connection with his
        commencement of employment, Mr. Steib will be granted a restricted stock unit award with a grant date value of $4,000,000 and a performance stock unit award with a target grant date value of $2,000,000, which collectively represent his long-term
        incentive opportunity for 2024 and a make-whole of certain compensation he forfeited in connection with the termination of his employment with his prior employer.&#160; From and after 2025, Mr. Steib will be eligible to participate in the Company&#8217;s long
        term incentive program, with a target long-term incentive opportunity of 550% of his annual base salary.&#160; Mr. Steib will be eligible to participate in the Company&#8217;s benefit plans and programs, including the Company&#8217;s Executive Severance Plan and
        Change in Control Severance Plan.&#160; The offer letter also contains a perpetual nondisclosure covenant.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Letter Agreement with Mr. Lougee</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On June 17, 2024, the Company and Mr. Lougee entered into a letter agreement, which provides that, as of the Transition Date, Mr. Lougee
        will retire as President and Chief Executive Officer and assume the position of Senior Advisor.&#160; Mr. Lougee&#8217;s employment as Senior Advisor will continue until August 31, 2025 (such period, the &#8220;Advisory Period&#8221;), unless terminated earlier in
        accordance with the terms of the letter agreement.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The letter agreement provides that, in consideration for his services as Senior Advisor, Mr. Lougee will receive an annual base salary of
        $550,000 and will be eligible for an annual bonus for 2024, based on actual performance for the full year and prorated based on his period of service in 2024 as President and Chief Executive Officer of the Company.&#160; Any equity awards and the cash
        retention award that Mr. Lougee holds as of the Transition Date will continue to vest during the Advisory Period.&#160; The letter agreement provides that any restrictive covenants applicable to Mr. Lougee as of the Transition Date will continue to
        apply during the Advisory Period.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If the Company terminates the Advisory Period without cause prior to August 31, 2025, Mr. Lougee will remain eligible for the
        compensation and benefits contemplated by the letter agreement.&#160; If the Advisory Period terminates due to Mr. Lougee&#8217;s death or disability, Mr. Lougee will remain eligible for a prorated annual bonus for 2024 and continued vesting of certain cash
        retention and equity awards granted in August 2023.&#160; The foregoing severance benefits are subject to Mr. Lougee&#8217;s execution of a release of claims and compliance with all applicable restrictive covenants.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing descriptions of the terms and conditions of the offer letter with Mr. Steib and the letter agreement with Mr. Lougee do not
        purport to be complete and are qualified in their entirety by reference to the full text thereof, which are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K, respectively, and are incorporated herein by reference.</div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">


  <tr>

    <td style="width: 10%; text-align: left; vertical-align: bottom;"><span style="font-weight: bold;">Item 7.01.</span><br/>
              </td>

    <td style="width: 90%; text-align: left; vertical-align: bottom;"><span style="font-weight: bold;">Regulation FD Disclosure.</span><br/>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A copy of the press release issued by the Company on June 17, 2024 regarding the executive transition and director appointments is
        furnished as Exhibit 99.1 to Current Report on Form 8-K.</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This information shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing
        under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div><br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">


  <tr>

    <td style="width: 10%; text-align: left; vertical-align: bottom;"><span style="font-weight: bold;">Item 9.01.</span><br/>
              </td>

    <td style="width: 90%; text-align: left; vertical-align: bottom;"><span style="font-weight: bold;">Financial Statements and Exhibits.</span><br/>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)&#160; Exhibits.</div>

    </div>

    <div><br/>
    </div>

    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">


  <tr>

    <td style="width: 10%; text-align: left; vertical-align: bottom;">
              <div><span style="text-decoration: underline;"><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Exhibit</span></span></div>
              <div><span style="text-decoration: underline;"><span style="font-weight: bold;">Number</span></span></div>
              <div><span style="text-decoration: underline;"><span style="font-weight: bold;"> <br/>
                  </span></span></div>
            </td>

    <td style="width: 90%; text-align: left; vertical-align: top;">
              <div><span style="text-decoration: underline;"><span style="font-weight: bold;"> <br/>
                  </span></span></div>
              <div><span style="text-decoration: underline;"><span style="font-weight: bold;">Description</span></span><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; text-align: left; vertical-align: top;"><a href="tgna8k_ex10-1.htm">10.1</a></td>

    <td rowspan="1" style="width: 90%; text-align: left; vertical-align: top;">
              <div><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Offer Letter, dated as of June 17, 2024, by and between TEGNA Inc. and Michael Steib.</span></div>
              <div><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"> <br/>
                </span></div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; text-align: left; vertical-align: top;"><a href="tgna8k_ex10-2.htm">10.2</a></td>

    <td rowspan="1" style="width: 90%; text-align: left; vertical-align: top;">
              <div><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Letter Agreement, dated as of June 17, 2024, by and between TEGNA Inc. and David T. Lougee.</span></div>
              <div><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"> <br/>
                </span></div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; text-align: left; vertical-align: top;"><a href="tgna8k_ex99-1.htm">99.1</a></td>

    <td rowspan="1" style="width: 90%; text-align: left; vertical-align: top;">
              <div><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">Press Release, dated as of June 17, 2024.</span></div>
              <div><span style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;"> <br/>
                </span></div>
            </td>

  </tr>


</table>
    </div>

    <div>
      <div><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div><br/>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div><br/>
      </div>

      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
        behalf by the undersigned hereunto duly authorized.</div>

      <div><br/>
      </div>

    </div>

    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">


  <tr>

    <td style="width: 55%;">
              <div> <br/>
              </div>
              <div>Date:&#160; June 20, 2024</div>
            </td>

    <td style="width: 45%;">
              <div><span style="font-weight: bold;">TEGNA INC.</span></div>
              <div><span style="font-weight: bold;"> <br/>
                </span></div>
              <div>
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">By:&#160; <span style="text-decoration: underline;">/s/ Marc S. Sher</span></span><span style="display: inline-block; text-indent: 0px; font-size: 1px; width: 216pt" class="TRGRRTFtoHTMLTab">&#160;</span></div>
                <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Marc S. Sher</div>
                <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Vice President, Associate General Counsel and Secretary</div>
                <span style="font-weight: bold;"> </span></div>
            </td>

  </tr>


</table>
    </div>

    <div><br/></div>

    <div><br/>
    </div>

    <div><br/>
    </div>

    <div><br/>
    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tgna8k_ex10-1.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Wachtell Lipton Rosen & Katz
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div class="BRPFPageHeader" style="width: 100%;">
    <div style="text-align: right;"><font style="font-weight: bold; font-size: 12pt;">Exhibit 10.1</font><br>
    </div>
  </div>
  <div>
    <div style="text-align: center;"><img width="207" height="86" src="image00002.jpg"></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">June 17, 2024</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Michael Steib</div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">c/o TEGNA Inc.</div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">8350 Broad Street, Suite 2000</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Tysons, Virginia&#160; 22102-5151</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Dear Michael:</div>
    <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">We are delighted to extend you an offer to join TEGNA Inc. (&#8220;TEGNA&#8221;) as President and Chief Executive Officer on the terms set forth
      below.&#160; This is a Full-Time, Exempt position<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">.</font></div>
    <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Listed below is more information about the offer effective upon your acceptance:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z8db741e4c01c4a22bda5feb7c71458ea">

        <tr>
          <td style="width: 36.5%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">TITLE:</div>
          </td>
          <td style="width: 63.5%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">President and Chief Executive Officer of TEGNA</div>
          </td>
        </tr>
        <tr>
          <td style="width: 36.5%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">REPORTS TO:</div>
          </td>
          <td style="width: 63.5%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Board of Directors of TEGNA (the &#8220;Board&#8221;)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 36.5%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">TARGET START DATE:</div>
          </td>
          <td style="width: 63.5%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">August 12, 2024</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-right: 5.75pt; margin-top: 13.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Annual Base
          Salary</u>:</font>&#160; You will receive an annual base salary, payable bi-weekly, at an annual rate of $1,000,000.</div>
    <div style="text-align: justify; margin-right: 5.7pt; margin-top: 13.8pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Annual Performance Bonus</u>:&#160; </font>You will be eligible to participate in an annual bonus plan as in effect from time to time for executive officers of TEGNA, contingent upon your performance and company performance, the availability
      of funds in the bonus pool and your continued employment with TEGNA through the payment date, which will be the date that bonuses are generally paid to other senior executives of TEGNA (which is currently expected to be not later than March 15 of the
      calendar year following the year in respect of which the bonus is payable).&#160; Your target annual bonus opportunity will be 150% of your annual base salary (i.e., $1,500,000 upon your start date).&#160; Notwithstanding the foregoing, your 2024<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>annual bonus will be paid at the target level and prorated based on the number of days you are employed by TEGNA during 2024, subject to your
      continued employment through the payment date.</div>
    <div style="text-align: justify; margin-right: 5.55pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Long-Term
          Incentive</u>:&#160; </font>As soon as administratively practicable following your start date (expected to be September 1, 2024, based on a start date of August 12, 2024), TEGNA will grant you a long-term incentive award with a grant date value
      (based on the closing trading price of one share of TEGNA common stock on the grant date, as adjusted to reflect the fact that dividend equivalents are not payable in respect of the awards) of $6,000,000, which will be granted 2/3 in the form of
      restricted stock units (&#8220;RSUs&#8221;) and 1/3 in the form of performance stock units (&#8220;PSUs&#8221;) pursuant to the TEGNA Inc. 2020 Omnibus Incentive Compensation Plan (the &#8220;2020 Plan&#8221;). This one-time grant represents your long-term incentive opportunity for
      2024 and a make-whole of certain compensation you forfeited upon the termination of your employment with your prior employer.&#160; Such RSUs and PSUs will be granted, in general, subject to the same forms of award agreements, and subject to the same
      vesting schedule, as the RSUs and PSUs granted to other members of TEGNA&#8217;s leadership team in 2024, the forms of which are attached to this letter agreement as Exhibit A and Exhibit B, respectively; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">provided</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">,</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">
        however</font>, that notwithstanding the foregoing, in the event of a termination of your employment prior to a Change in Control (as defined in the TCSP) either without &#8220;cause&#8221; (as defined below) by TEGNA or by you for &#8220;good reason&#8221; (as defined
      below), you will become fully vested in&#160;any then-unvested RSUs and PSUs held by you at such time (with such PSUs remaining outstanding and subject to vesting based on actual performance in accordance with the PSU award agreement, at the end of the
      applicable performance period).</div>
    <div style="text-align: justify; margin-right: 5.55pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">For purposes of the immediately preceding paragraph:</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z25c429b16293433689119779ec86c01b">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 18pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="margin: 0px 0px 0px; font-family: 'Times New Roman', Times, serif; font-size: 12pt; text-align: justify;">The term &#8220;cause&#8221; shall have the meaning set forth in the TEGNA Inc. Executive Severance Plan, as amended through February
                21, 2024 (the &#8220;TESP&#8221;) and the TEGNA Inc. 2015 Change in Control Severance Plan, as amended through February 21, 2024 (the &#8220;TCSP&#8221;), depending on which plan is applicable to you at the time of termination.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcaaac71f13ba4b16bd45b995765415d2">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 18pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="margin: 0px 0px 0px; font-family: 'Times New Roman', Times, serif; font-size: 12pt; text-align: justify;">The term &#8220;good reason&#8221; (a)&#160;prior to a Change in Control, shall mean TEGNA&#8217;s material breach of any of the terms of this
                letter agreement and (b)&#160;following a Change in Control, shall have the meaning set forth in the TCSP.&#160; In each case, any such termination shall be subject to your prior notice and TEGNA shall have an opportunity to cure, in accordance with
                the processes for such applicable termination of employment as set forth under the TCSP.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; margin-right: 5.55pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">For 2025 and going forward, you will be eligible to participate in TEGNA&#8217;s Long Term Incentive Program as in
      effect from time to time (&#8220;LTIP&#8221;), pursuant to which you will be granted equity-based awards pursuant to the 2020 Plan (or any successor plan).&#160; Your target long-term incentive opportunity under the LTIP will be 550% of your annual base salary (i.e.,
      $5,500,000).&#160; Your annual award is anticipated to be granted 70% in the form of PSUs and 30% in the form of RSUs. The annual award will be determined by the Leadership Development and Compensation Committee of the Board, with the final award value
      based upon your performance and guidelines in place at the time and always subject to change at the Board&#8217;s discretion.&#160; Please keep in mind that TEGNA reserves the right to amend, alter or eliminate the LTIP at any time or for any reason.</div>
    <div style="text-align: justify; margin-right: 5.7pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Duties and
          Authorities; Board Service</u>:</font>&#160; As President and Chief Executive Officer of TEGNA, you will have the duties and authorities normally associated with the position of chief executive officer of a publicly traded company of similar size and
      nature.&#160; On your start date, you will be appointed as a member of the Board. You will not receive additional compensation for service on the Board.</div>
    <div style="text-align: justify; margin-right: 5.7pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Workplace
          Location</u>:</font> Your primary work locations will, in your reasonable discretion, be New York, NY and Tysons, VA, in addition to such business travel as reasonably necessary to perform your duties.</div>
    <div style="text-align: justify; margin-right: 5.7pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>TEGNA
          Executive Severance and Change in Control Severance</u>:&#160; </font>You will be eligible to participate in the TESP and TCSP, in each case, as in effect from time to time.&#160; In the event of a qualifying termination of employment under the terms of
      the TESP or TCSP (as applicable), you shall be entitled to the payments and benefits provided under Section 7 of the TESP (which provides the Chief Executive Officer with, among other things, a severance multiple of 2.0x) or under Section 7 of the
      TCSP (which provides the Chief Executive Officer with, among other things, a severance multiple of 2.99x), as applicable, in each case, subject to the applicable plan terms.</div>
    <div style="text-align: justify; margin-right: 5.65pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Stock
          Ownership Guideline</u>:&#160; </font>As President and Chief Executive Officer, TEGNA&#8217;s stock ownership guideline policy will require that you hold TEGNA stock at least five times (5x) your annual base salary.&#160; This includes any unvested RSUs and
      PSUs for which performance has been certified.&#160; If you fall below this guideline, you will be required to hold all after-tax shares you receive from TEGNA as compensation until you meet the guideline, to the extent applicable under the policy.</div>
    <div style="text-align: justify; margin-right: 5.6pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Benefits</u>:&#160;
      </font>Upon the appropriate waiting period for each plan and determined by your employment status and business unit, you will be eligible for the standard TEGNA benefits programs, including, but not limited to, health and life insurance coverage and
      401(k) plan participation.&#160; Please note that, if applicable, your health/dental/vision insurance begins on the first day of the month following your start date.&#160; Additional information regarding our employee benefits can be found in our Benefits
      Summary document, and details on enrollment, if applicable, will be provided after you start employment with TEGNA.</div>
    <div style="text-align: justify; margin-right: 5.65pt; margin-top: 0.05pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Paid Time Off</u>:&#160; </font>TEGNA promotes a flexible approach to time off by combining vacation, sick days and floating holidays.&#160; Please refer to the PTO policy document in your offer letter package for the accrual schedule and
      additional details.</div>
    <div style="text-align: justify; margin-right: 5.65pt; margin-top: 0.05pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Business Expenses</u>:&#160; </font>Business expenses incurred in connection with your service to TEGNA will be subject to reimbursement to the extent contemplated by TEGNA&#8217;s expense reimbursement practice, as in effect from time to time.&#160;
      Without limiting the generality of the foregoing, TEGNA will provide reimbursement to you of all travel-related expenses that you incur in performance of your duties, including in connection with your travel between New York, NY and Tysons, VA, to
      the same extent as executive officers of TEGNA receive reimbursement for business travel expenses pursuant to the TEGNA expense reimbursement practice applicable to such executives.</div>
    <div style="text-align: justify; margin-right: 5.75pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Tax
          Withholding</u>:&#160; </font>All dollar amounts set forth herein are gross amounts and are subject to applicable tax withholding.</div>
    <div style="text-align: justify; margin-right: 5.75pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Employee
          Representations</u>:&#160; </font>TEGNA has successfully completed a pre-employment background investigation and employment verifications as a condition precedent to making this offer of employment to you. You represent and warrant that all matters
      provided by you in connection with the foregoing were truthful, without intentional misrepresentation or intentional deletion of material information<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">.</font></div>
    <div style="text-align: justify; margin-right: 5.6pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>Confidentiality</u>:&#160;


      </font>You recognize and acknowledge that certain confidential business and technical information of TEGNA, including, but not limited to, information relating to financial statements, customer identities, potential customers, employees, suppliers,
      servicing methods, equipment, program strategies and information, databases and information systems, analyses, digital products, profit margins, or other proprietary information used by TEGNA, is a valuable, special and unique asset of TEGNA.&#160; You
      shall not, at any time, whether during or after your employment with TEGNA or any of its affiliates, use such information, or any part thereof, or disclose such information to any person, firm, corporation, association or other entity for any purpose
      other than for the benefit of TEGNA.</div>
    <div style="text-align: justify; margin-right: 5.65pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>At-Will
          Employment</u>:&#160; </font>This employment relationship is considered &#8220;at will&#8221; and may be terminated, with advance written notice, by you to the Chairman of the Board of Directors of TEGNA, or by such Chairman to you, as applicable.</div>
    <div style="text-align: justify; margin-right: 5.65pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>No Conflicts;
          Outside Commitments</u>:&#160; </font>You represent and warrant that you have the full legal right to enter into employment with TEGNA at this time, and that you have not made, and will not make, any commitments, or entered into agreements (oral or
      written) with any other person or entity, that may be in conflict with your employment at TEGNA. You acknowledge and agree that, during the period of your employment with TEGNA, you may serve on only one board (or equivalent body) of a for-profit
      entity (whether public of private) and provided that such service does not unreasonably interfere with or detract from the performance of your duties and responsibilities to TEGNA.&#160; For the avoidance of doubt, TEGNA acknowledges and confirms that (a)
      the foregoing shall not prevent you from managing your personal investments and (b) your service on the boards of directors identified in Appendix I to this letter agreement shall not constitute conflicts with your employment at TEGNA and that you
      may, in your discretion, continue to serve on one or both such boards.</div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="text-align: center;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">*</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">*</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font>*</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-right: 5.75pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">We look forward to having you join in what we expect will be a mutually rewarding relationship and productive
      experience.&#160; If you have any questions, please feel free to contact me directly.</div>
    <div style="text-align: justify; margin-bottom: 30pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Best regards,</div>
    <div style="text-align: justify; margin-bottom: 30pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">/s/ Howard D. Elias</div>
    <div style="text-align: left; margin-right: 318pt; margin-top: 0.05pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">Howard D. Elias</div>
    <div style="text-align: left; margin-right: 265.5pt; margin-top: 0.05pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Chairman of the Board of Directors</div>
    <div style="text-align: justify; margin-bottom: 30pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">TEGNA Inc.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 30pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">Acceptance</div>
    <div style="text-align: justify; margin-bottom: 30pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">
      <table cellspacing="0" cellpadding="0" border="0" id="ze2798390e0d142a9b9a8866b4340bc64" style="width: 50%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

          <tr>
            <td style="width: 10%; padding-bottom: 2px;">
              <div style="font-size: 12pt;">&#160;Signature:<br>
              </div>
            </td>
            <td colspan="1" style="width: 40%; text-align: center; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 12pt;">/s/ Michael Steib<br>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 10%; font-size: 12pt;">&#160;</td>
            <td colspan="1" rowspan="1" style="width: 40%; text-align: center; vertical-align: top; font-size: 12pt;">&#160;Michael Steib<br>
            </td>
          </tr>

      </table>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 12pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div style="text-align: center;">[Signature Page to Offer Letter]<br>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Appendix I</div>
    <div style="text-align: center; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Chairman, Board of Directors, <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>change.org</u></font></div>
    <div style="text-align: center; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Member, Board of Directors, Artsy (<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>artsy.net</u></font>)*</div>
    <div style="margin-bottom: 24pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000; margin-bottom: 24pt;" class="DSPFListTable" id="z4cc41943a7764bb59d690467d2e71b40">

        <tr>
          <td style="width: 22.5pt;"><br>
          </td>
          <td style="width: 13.5pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">*</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;">For the avoidance of doubt, so long as you serve on this Board of Directors, you may not serve on the board of directors (or equivalent body) of any other for-profit
              entity (whether public of private).</div>
          </td>
        </tr>

    </table>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-size: 12pt;">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div style="text-align: center;">A-1<br>
        </div>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;"> Exhibit A<br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">AWARD AGREEMENT</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">STOCK UNITS</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
      <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">The Leadership Development and Compensation Committee</font>&#160;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">of the TEGNA Inc. Board of Directors has approved an award of Restricted Stock Units (referred to herein as &#8220;Stock Units&#8221;) to you under the TEGNA Inc. 2020 Omnibus Incentive
          Compensation Plan (the &#8220;Plan&#8221;), as set forth below.</font></div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
      <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">This Award Agreement and the enclosed Terms and Conditions effective as of #GrantDate#, constitute the formal agreement governing this
        award.</div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
      <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Please sign both copies of this Award Agreement to evidence your agreement with the terms hereof.&#160; Keep one copy and return the other
        to the undersigned.</div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
      <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Please keep the enclosed Terms and Conditions for future reference.&#160;</div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3f16a2794cd64e5fad28cbf71fea8fc4">

          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Employee:</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">#ParticipantName#</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Grant Date:</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">#GrantDate#</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Stock Unit Commencement Date:</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">3/1/24</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Stock Unit Expiration Date:</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">2/28/28</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Stock Unit Vesting Schedule:</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">25% of the Stock Units shall vest on 2/28/25*</div>
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">25% of the Stock Units shall vest on 2/28/26*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">25% of the Stock Units shall vest on 2/28/27*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">25% of the Stock Units shall vest on 2/29/28*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Payment Date:</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">25% of the Stock Units shall vest on 3/1/25*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">25% of the Stock Units shall vest on 3/1/26*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">25% of the Stock Units shall vest on 3/1/27*</div>
            </td>
          </tr>
          <tr>
            <td style="width: 42.44%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 57.56%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">25% of the Stock Units shall vest on 3/1/28*</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 12pt;">*</font>&#160; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">Provided the Employee is
          continuously employed until such vesting dates and has not terminated employment on or before such vesting dates.&#160; Such dates are hereinafter referred to as the &#8220;Vesting Date&#8221; or &#8220;Payment Date&#8221; for the Stock Units that vest or are paid on such
          dates.</font></div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
      <div style="text-align: justify;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">Number of Stock Units:</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 288pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">#QuantityGranted#</font></div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zca45dc83c1d94b9eba5ea71e93c60ddb">

          <tr>
            <td style="width: 47.81%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 4.54%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 47.65%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">TEGNA Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 47.81%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 4.54%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">By:</div>
            </td>
            <td style="width: 47.65%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 47.81%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Employee&#8217;s Signature or Acceptance by&#160;</div>
            </td>
            <td style="width: 4.54%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 47.65%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Jeffery Newman</div>
            </td>
          </tr>
          <tr>
            <td style="width: 47.81%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Electronic Signature</div>
            </td>
            <td style="width: 4.54%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
            </td>
            <td style="width: 47.65%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Senior Vice President/Human Resources</div>
            </td>
          </tr>

      </table>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-2-</font></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%-%-%-->
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160; <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">STOCK UNITS</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">TERMS AND CONDITIONS</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Under the</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">TEGNA Inc.</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">2020 Omnibus Incentive Compensation Plan</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
      <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">These Terms and Conditions, dated #GrantDate#, govern the grant of Restricted Stock Units (referred to herein as &#8220;Stock Units&#8221;) to the
        employee (the &#8220;Employee&#8221;) designated in the Award Agreement dated coincident with these Terms and Conditions.&#160; The Stock Units are granted under, and are subject to, the TEGNA Inc. (the &#8220;Company&#8221;) 2020 Omnibus Incentive Compensation Plan (the
        &#8220;Plan&#8221;).&#160; Terms used herein that are defined in the Plan shall have the meanings ascribed to them in the Plan.&#160; If there is any inconsistency between these Terms and Conditions and the terms of the Plan, the Plan&#8217;s terms shall supersede and replace
        the conflicting terms herein.</div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">1.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Grant of Stock Units</u></font>.&#160; Pursuant to the provisions of (i) the Plan, (ii) the
          individual Award Agreement governing the grant, and (iii) these Terms and Conditions, the Company has granted to the Employee the number of Stock Units set forth on the applicable Award Agreement.&#160; Each vested Stock Unit shall entitle the
          Employee to receive from the Company one share of the Company's common stock (&#8220;Common Stock&#8221;) upon the earliest of the Employee&#8217;s termination of employment, a Change in Control (but only to the extent provided in Section 14) or the Payment Date,
          as defined below.&#160; The Employee shall not be entitled to receive any shares of Common Stock with respect to unvested Stock Units, and the Employee shall have no further rights with regard to a Stock Unit once the underlying share of Common Stock
          has been delivered with respect to that Stock Unit.</font></div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-3-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">2.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Payment Date</u></font>.&#160; The Payment Date shall be the dates specified in the Award Agreement
          with respect to the Stock Units that are vested on such date under the schedule set forth in the Award Agreement.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">3.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Vesting Schedule</u></font>.&#160; Subject to the special vesting rules set forth in Sections 7 and
          14, the Stock Units shall vest in accordance with the Vesting Schedule specified in the Award Agreement to the extent that the Employee is continuously employed by the Company or its Subsidiaries until the Vesting Dates specified in the Vesting
          Schedule and has not terminated employment on or before such dates.&#160; An Employee will not be treated as remaining in continuous employment if the Employee&#8217;s employer ceases to be a Subsidiary of the Company.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">4.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>No Dividend Equivalents</u></font>.&#160; No dividend equivalents shall be paid to the Employee with
          regard to the Stock Units.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">5.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Delivery of Shares</u></font>.&#160; The Company shall deliver to the Employee a certificate or
          certificates, or at the election of the Company make an appropriate book-entry, for the number of shares of Common Stock equal to the number of vested Stock Units as soon as administratively practicable (but always by the 30th day) after the
          earliest of the Employee&#8217;s termination of employment, a Change in Control (but only to the extent provided in Section 14) or the Payment Date.&#160; The number of shares delivered shall be reduced by the value of all taxes withheld by reason of such
          delivery; provided that the amount that is withheld, or may be withheld at the Employee&#8217;s discretion, cannot exceed the amount of the taxes owed by the Employee using the maximum statutory tax rate in the Employee&#8217;s applicable jurisdiction(s).&#160;
          The Employee shall not be entitled to receive any shares of Common Stock with respect to unvested Stock Units, and the Employee shall have no further rights with regard to a Stock Unit once the underlying share of Common Stock has been delivered
          with respect to that Stock Unit.</font></div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-4-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">6.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Cancellation of Stock Units</u></font>.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Termination of Employment</u></font>.&#160; Subject to
          Sections 7 and 14, all Stock Units granted to the Employee that have not vested as of the date of the Employee&#8217;s termination of employment shall automatically be cancelled upon the Employee&#8217;s termination of employment.&#160; Unvested Stock Units shall
          also be cancelled in connection with an event that results in the Employee&#8217;s employer ceasing to be a Subsidiary of the Company.</font></div>
      <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Forfeiture of Stock Units/Recovery of Common Stock</u></font>.&#160; Stock Units granted under this
          Award Agreement are subject to the Company&#8217;s Recoupment Policy, dated as of February 26, 2013, as amended as of December 7, 2018, and which may be further amended from time-to-time with retroactive effect.&#160; In addition, the Company may assert any
          other remedies that may be available to the Company under applicable law, including, without limitation, those available under Section 304 of the Sarbanes-Oxley Act of 2002.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">7.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Death, Disability, Retirement</u></font>.&#160; In the event that the Employee&#8217;s employment
          terminates on or prior to the Stock Unit Expiration Date by reason of death, permanent disability (as determined under the Company&#8217;s Long Term Disability Plan), termination of employment after attaining age 65 (other than for &#8220;Cause&#8221;), or
          termination of employment after both attaining age 55 and completing at least 5 years of service (other than for &#8220;Cause&#8221;), the Employee (or in the case of the Employee's death, the Employee's estate or designated beneficiary) shall become vested
          in a number of Stock Units equal to the product of (i) the total number of Stock Units in which the Employee would have become vested upon the Stock Unit Expiration Date had the Employee's employment not terminated, and (ii) a fraction, the
          numerator of which shall be the number of full calendar months between the Stock Unit Commencement Date and the date that employment terminated, and the denominator of which shall be the number of full calendar months from the&#160;</font></div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-5-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Stock Unit Commencement Date to the Stock Unit Expiration Date; provided such number of Stock Units so vested shall be reduced by the number of Stock
        Units that had previously become vested.&#160; In the event the Employee is terminated for &#8220;Cause&#8221; all unpaid awards shall be forfeited.&#160; &#8220;Cause&#8221; shall mean a termination of the Employee&#8217;s employment following the occurrence of any of the following
        events, each of which shall constitute a &#8220;Cause&#8221; for such termination:</div>
      <div>
        <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160; any material misappropriation of funds or property of the Company or its affiliate by the Employee;</div>
        <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(ii)&#160;&#160;&#160;&#160; unreasonable and persistent neglect or refusal by the Employee to perform his or her duties which is not remedied within
          thirty (30) days after receipt of written notice from the Company;</div>
        <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(iii)&#160;&#160;&#160;&#160; conviction, including a plea of guilty or of nolo contendere, of the Employee of a securities law violation or a felony;</div>
        <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(iv)<font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160; </font>material violation of the
          Company&#8217;s employment policies by the Employee; or</div>
        <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(v)<font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160; </font>material harm to the Company<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font>(financial, competitive, reputational or otherwise) caused by the Employee&#8217;s gross negligence, intentional misconduct or knowing or reckless disregard of supervisory
          responsibility for a direct report who engaged in gross negligence or intentional misconduct.</div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">The Committee, in its sole discretion, shall be responsible for making the determination whether an Employee&#8217;s termination is for &#8220;Cause&#8221;, and its
        decision shall be binding on all parties.</div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">8.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Non-Assignability</u></font>.&#160; Stock Units may not be transferred, assigned, pledged or
          hypothecated, whether by operation of law or otherwise, nor may the Stock Units be made subject to execution, attachment or similar process.</font></div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;&#160; <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-6-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">9.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Rights as a Shareholder</u></font>.&#160; The Employee shall have no rights as a shareholder by
          reason of the Stock Units.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">10.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Discretionary Plan; Employment</u></font>.&#160; The Plan is
          discretionary in nature and may be suspended or terminated by the Company at any time. With respect to the Plan, (a) each grant of Stock Units is a one-time benefit which does not create any contractual or other right to receive future grants of
          Stock Units, or benefits in lieu of Stock Units; (b) all determinations with respect to any such future grants, including, but not limited to, the times when the Stock Units shall be granted, the number of Stock Units, the Vesting Dates and the
          Payment Dates, will be at the sole discretion of the Company; (c) the Employee&#8217;s participation in the Plan shall not create a right to further employment with the Employee&#8217;s employer and shall not interfere with the ability of the Employee&#8217;s
          employer to terminate the Employee&#8217;s employment relationship at any time with or without cause; (d) the Employee&#8217;s participation in the Plan is voluntary; (e) the Stock Units are not part of normal and expected compensation for purposes of
          calculating any severance, resignation, redundancy, end of service payment, bonuses, long-service awards, pension or retirement benefits, or similar payments; and (f) the future value of the Stock Units is unknown and cannot be predicted with
          certainty.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">11.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Effect of Plan and these Terms and Conditions</u></font>.&#160;
          The Plan is hereby incorporated by reference into these Terms and Conditions, and these Terms and Conditions are subject in all respects to the provisions of the Plan, including without limitation the authority of the Leadership Development and
          Compensation Committee of the Board of Directors of the Company (the &#8220;Committee&#8221;) in its sole discretion to adjust awards and to make interpretations and other determinations with respect to all matters relating to the applicable Award
          Agreements, these Terms and Conditions, the Plan and awards made pursuant thereto. These Terms and Conditions&#160;</font></div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160; <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-7-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">shall apply to the grant of Stock Units made to the Employee on the date hereof and shall not apply to any future grants of Stock Units made to the
        Employee.</div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">12.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Notices</u></font>.&#160; Notices hereunder shall be in
          writing and if to the Company shall be addressed to the Secretary of the Company at 8350 Broad Street, Suite 2000, Tysons, Virginia 22102, and, if to the Employee, shall be addressed to the Employee at his or her address as it appears on the
          Company's records.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">13.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Successors and Assigns</u></font>.&#160; The applicable Award
          Agreement and these Terms and Conditions shall be binding upon and inure to the benefit of the successors and assigns of the Company and, to the extent provided in Section 7 hereof, to the estate or designated beneficiary of the Employee.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">14.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Change in Control Provisions</u></font>.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Notwithstanding anything to the contrary in these Terms and Conditions, the following provisions shall apply to all Stock Units
        granted under the attached Award Agreement.</div>
      <div>
        <div style="text-align: justify; text-indent: 81.6pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 26.4pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Definitions</u></font>.</font></div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 81.6pt; margin-bottom: 5.05pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">As used in Articles 2 and 14 of the Plan and in these Terms and Conditions, a &#8220;Change in Control&#8221; shall
          mean the first to occur of the following:</div>
      </div>
      <div style="text-align: justify; text-indent: 122.4pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 21.6pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a &#8220;Person&#8221;)
          of beneficial ownership (within the meaning of Rule 13d&#8209;3 promulgated under the Exchange Act) of 20% or more of either (A) the then-outstanding shares of common stock of the Company (the &#8220;Outstanding Company Common Stock&#8221;) or (B) the combined
          voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the &#8220;Outstanding Company Voting Securities&#8221;); provided, however, that, for purposes of this Section, the following&#160;</font></div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-8-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">acquisitions shall not constitute a Change in Control:&#160; (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any
        acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or one of its affiliates or (iv) any acquisition pursuant to a transaction that complies with Sections 14(a)(iii)(A), 14(a)(iii)(B) and
        14(a)(iii)(C);</div>
      <div style="text-align: justify; text-indent: 122.4pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 57.6pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">individuals who, as of the date hereof, constitute the Board (the &#8220;Incumbent Board&#8221;) cease for any reason to constitute at least a
          majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least a majority of the directors
          then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or
          threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board;</font></div>
      <div style="text-align: justify; text-indent: 122.4pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 57.6pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">consummation of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the
          Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any of its subsidiaries (each, a &#8220;Business
          Combination&#8221;), in each case, unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting
          Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding&#160;</font></div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-9-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation or entity resulting from such Business
        Combination (including, without limitation, a corporation or entity that, as a result of such transaction, owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries) in substantially
        the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any employee benefit plan (or
        related trust) of the Company or any corporation or entity resulting from such Business Combination) beneficially owns, directly or indirectly, 20% or more of, respectively, the then-outstanding shares of common stock of the corporation or entity
        resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation or entity, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a
        majority of the members of the board of directors of the corporation or entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board
        providing for such Business Combination; or</div>
      <div style="text-align: justify; text-indent: 122.4pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(iv)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 57.6pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.</font></div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Acceleration Provisions</u></font>.&#160;
          (i)&#160; In the event of the occurrence of a Change in Control in which the Stock Units are not continued or assumed (i.e., the Stock Units are not equitably converted into, or substituted for, a right to receive cash and/or equity of a successor
          entity or its affiliate), the Stock Units that have not been cancelled or paid out shall become fully vested.&#160; The vested Stock Units shall be paid out to the Employee as soon as administratively practicable on or following the effective date of
          the Change in Control (but in no event later than 30 days after such </font>event); provided that the Change in Control also constitutes a change in ownership or effective control of the Company or a change in the ownership of a substantial
        portion of the assets of the Company within the meaning of Section 409A of the Internal Revenue Code of 1986 (the &#8220;Code&#8221;) and the regulations and guidance issued thereunder (&#8220;Section 409A&#8221;), and such payout will not result in additional taxes under
        Section 409A.&#160; Otherwise, the vested Stock Units shall be paid out as soon as administratively practicable after the earlier of the Employee&#8217;s termination of employment or the applicable Payment Date for such Stock Units (but in no event later than
        30 days after such events).</div>
      <div style="text-align: justify; text-indent: 77.2pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 30.8pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">In the event of the occurrence of a Change in Control in which the Stock Units are continued or assumed (i.e., the Stock Units are
          equitably converted into, or substituted for, a right to receive cash and/or equity of a successor entity or its affiliate), the Stock Units shall not vest upon the Change in Control, provided that the Stock Units that are not subsequently vested
          and paid under the other provisions of this Award shall become fully vested in the event that the Employee has a &#8220;qualifying termination of employment&#8221; within two years following the date of the Change in Control.&#160; In the event of the occurrence
          of a Change in Control in which the Stock Units are continued or assumed, vested Stock Units shall be paid out as soon as administratively practicable after the earlier of the Employee&#8217;s termination of employment or the applicable Payment Date
          for such Stock Units (but in no event later than 10 days after such events).</font></div>
      <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">A &#8220;qualifying termination of employment&#8221; shall occur if the Company involuntarily terminates the Employee without &#8220;Cause&#8221; or the
        Employee voluntarily terminates for &#8220;Good Reason&#8221;.&#160; For this purpose, &#8220;Cause&#8221; shall mean:</div>
      <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 100%;">

            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top;">
                <div style="font-size: 12pt;">&#8226;</div>
              </td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;"> <font style="font-size: 12pt;">any material misappropriation of funds or property of the Company or its affiliate by the Employee;</font> </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-10-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top;">
                <div style="font-size: 12pt;">&#8226;</div>
              </td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;"> <font style="font-size: 12pt;">unreasonable and persistent neglect or refusal by the Employee to perform his or her duties which is not remedied within thirty
                  (30) days after receipt of written notice from the Company; or</font> </td>
            </tr>
            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top; font-size: 12pt;" rowspan="1">&#8226;<br>
              </td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;" rowspan="1">conviction, including a plea of guilty or of nolo contendere, of the Employee of a securities law violation or a felony.</td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">For this purpose, &#8220;Good Reason&#8221; means the occurrence after a Change in Control of any of the following circumstances without the
        Employee&#8217;s express written consent, unless such circumstances are fully corrected within 90 days of the Notice of Termination described below:</div>
      <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top;">
                <div style="font-size: 12pt;">&#8226;</div>
              </td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;">
                <div>the material diminution of the Employee&#8217;s duties, authorities or responsibilities from those in effect immediately prior to the Change in Control;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top; font-size: 12pt;" rowspan="1">&#8226;<br>
              </td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;" rowspan="1">a reduction in the Employee&#8217;s base salary or target bonus opportunity as in effect on the date immediately prior to the Change in Control;</td>
            </tr>
            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top; font-size: 12pt;" rowspan="1">&#8226;</td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;" rowspan="1">failure to provide the Employee with an annual long-term incentive opportunity the grant date value of which is equivalent to or greater in value than
                Employee&#8217;s regular annual long-term incentive opportunity in effect on the date of the Change of Control (counting only normal long-term incentive awards made as a part of the regular annual pay package, not special awards not made on a
                regular basis), calculated using widely recognized valuation methodologies by an experienced compensation consultant at a nationally recognized firm;</td>
            </tr>
            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top; font-size: 12pt;" rowspan="1">&#8226;</td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;" rowspan="1">the relocation of the Employee&#8217;s office from the location at which the Employee is principally employed immediately prior to the date of the Change in
                Control to a location 35 or more miles farther from the Employee&#8217;s residence immediately prior to the Change in Control, or the Company&#8217;s requiring the Employee to be based anywhere other than the Company&#8217;s offices at such location, except
                for required travel on the Company&#8217;s business to an extent substantially consistent with the Employee&#8217;s business travel obligations prior to the Change in Control; or</td>
            </tr>
            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top; font-size: 12pt;" rowspan="1">&#8226;</td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;" rowspan="1">the failure by the Company or its affiliate to pay any compensation or benefits due to the Employee.</td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Any termination by the Employee for Good Reason shall be communicated by a Notice of Termination that (x) indicates the specific
        termination provision in the Award Agreement relied upon, and (y) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Employee&#8217;s employment under the provision so
        indicated.&#160; Such notice must be provided to the Company within ninety (90) days after the event&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-11-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">that created the &#8220;Good Reason&#8221;.</div>
      <div style="text-align: justify; text-indent: 77.2pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 30.8pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">If in connection with a Change in Control, the Stock Units are assumed (i.e., the Stock Units are equitably converted into, or
          substituted for, a right to receive cash and/or equity of a successor entity or its affiliate), the Stock Units shall refer to the right to receive such cash and/or equity.&#160; An assumption of this Stock Unit award must satisfy the following
          requirements:</font></div>
      <div style="text-align: justify; text-indent: 77.2pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top;">
                <div style="font-size: 12pt;">&#8226;</div>
              </td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;">
                <div>The converted or substituted award must be a right to receive an amount of cash and/or equity that has a value, measured at the time of such conversion or substitution, that is equal to the value of this Award as of the date of the
                  Change in Control;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top; font-size: 12pt;" rowspan="1">&#8226; <br>
              </td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;" rowspan="1">Any equity payable in connection with a converted or substituted award must be publicly traded equity securities of the Company, a successor company
                or their direct or indirect parent company, and such equity issuable with respect to a converted or substituted award must be covered by a registration statement filed with the Securities Exchange Commission that permits the immediate sale
                of such shares on a national exchange;</td>
            </tr>
            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top; font-size: 12pt;" rowspan="1">&#8226;</td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;" rowspan="1">The vesting terms of any converted or substituted award must be substantially identical to the terms of this Award; and</td>
            </tr>
            <tr>
              <td style="width: 7.5%; text-align: center; vertical-align: top; font-size: 12pt;" rowspan="1">&#8226;</td>
              <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;" rowspan="1">The other terms and conditions of any converted or substituted award must be no less favorable to the Employee than the terms of this Award are as of
                the date of the Change in Control (including the provisions that would apply in the event of a subsequent Change in Control).</td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">The determination of whether the conditions of this Section 14(b)(iii) are satisfied shall be made by the Committee, as constituted
        immediately before the Change in Control, in its sole discretion.&#160;</div>
      <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(c)&#160; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Legal Fees.</u></font>&#160; The Company shall pay
        all legal fees, court costs, fees of experts and other costs and expenses when incurred by Employee in connection with any actual, threatened or contemplated litigation or legal, administrative or other proceedings involving the provisions of this
        Section 14, whether or not initiated by the Employee.&#160; The Company agrees to pay such&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;<br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-12-</font></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">amounts within 10 days following the Company&#8217;s receipt of an invoice from the Employee, provided that the Employee shall have submitted an invoice for
        such amounts at least 30 days before the end of the calendar year next following the calendar year in which such fees and disbursements were incurred.</div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">15.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Employment or Similar Agreements.</u></font>&#160; The
          provisions of Sections 1, 3, 5, 6, 7 and 14 of these Terms and Conditions shall not be applied to or interpreted in a manner which would decrease the rights held by, or the payments owing to, an Employee under an employment agreement, termination
          benefits agreement or similar agreement with the Company that pre-exists the Grant Date and contains specific provisions applying to Plan awards in the case of any change in control or similar event or termination of employment, and if there is
          any conflict between the terms of such employment agreement, termination benefits agreement or similar agreement and the terms of Sections 1, 3, 5, 6, 7 and 14, the employment agreement, termination benefits agreement or similar agreement shall
          control.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">16.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Grant Subject to Applicable Regulatory Approvals</u></font>.&#160;
          Any grant of Stock Units under the Plan is specifically conditioned on, and subject to, any regulatory approvals required in the Employee&#8217;s country.&#160; These approvals cannot be assured.&#160; If necessary approvals for grant or payment are not
          obtained, the Stock Units may be cancelled or rescinded, or they may expire, as determined by the Company in its sole and absolute discretion.</font></div>
      <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">17.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Applicable Laws and Consent to Jurisdiction</u></font>.&#160;
          The validity, construction, interpretation and enforceability of this Agreement shall be determined and governed by the laws of the State of Delaware without giving effect to the principles of conflicts of law.&#160; For the purpose of litigating any
          dispute that arises under this Agreement, the parties hereby consent to exclusive&#160;</font></div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal;">-13-</font></div>
    </div>
    <div><br>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">jurisdiction in Virginia and agree that such litigation shall be conducted in the courts of Fairfax County, Virginia or the federal courts of the United
        States for the Eastern District of Virginia.</div>
      <div style="text-align: justify; text-indent: 40.8pt; margin-bottom: 6pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">18.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Compliance with Section 409A</u></font>.&#160; This Award is
          intended to comply with the requirements of Section 409A so that no taxes under Section 409A are triggered, and shall be interpreted and administered in accordance with that intent (e.g., the definition of &#8220;termination of employment&#8221; (or similar
          term used herein) shall have the meaning ascribed to &#8220;separation from service&#8221; under Section 409A).&#160; If any provision of these Terms and Conditions would otherwise conflict with or frustrate this intent, the provision shall not apply.&#160;
          Notwithstanding any provision in this Award Agreement to the contrary and solely to the extent required by Section 409A, if the Employee is a &#8220;specified employee&#8221; within the meaning of Code Section 409A and if delivery of shares is being made in
          connection with the Employee&#8217;s separation from service other than by reason of the Employee&#8217;s death, delivery of the shares shall be delayed until six months and one day after the Employee&#8217;s separation from service with the Company (or, if
          earlier than the end of the six-month period, the date of the Employee&#8217;s death).&#160; The Company shall not be responsible or liable for the consequences of any failure of the Award to avoid taxation under Section 409A.</font></div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2024</div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">US employees</div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;"> Exhibit B<br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">AWARD AGREEMENT</div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">PERFORMANCE SHARES</div>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">The Leadership Development and Compensation Committee of the TEGNA Inc. Board of Directors has approved your opportunity to receive
          Performance Shares (referred to herein as &#8220;Performance Shares&#8221;) under the TEGNA Inc. 2020 Omnibus Incentive Compensation Plan (the &#8220;Plan&#8221;), as set forth below.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">This Award Agreement and the enclosed Terms and Conditions effective as of #GrantDate#, constitute the formal agreement governing
          this award.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Please sign both copies of this Award Agreement to evidence your agreement with the terms hereof.&#160; Keep one copy and return the other
          to the undersigned.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Please keep the enclosed Terms and Conditions for future reference.&#160;</div>
        <div>
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1f5bc5f984f5466a978bee4eb4791f26">

            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Employee:</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">#ParticipantName#</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Grant Date:</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">#GrantDate#</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Performance Period Commencement Date:</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">March 1, 2024</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Performance Period End Date:</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div>
                  <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">February 28, 2027</div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Performance Share Payment Date:</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">March 1, 2027, or soon as administratively practicable thereafter but in all instances within the first two weeks of March 2027</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 29.5%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Target Number of Performance Shares:</div>
              </td>
              <td style="width: 70.5%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">#QuantityGranted#*</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">*&#160; The actual number of Performance Shares you may receive will be higher or lower depending on the Company&#8217;s actual performance versus targeted
          performance and your continued employment with the Company, as more fully explained in the enclosed Terms and Conditions.</div>
        <div>
          <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z351d6d97b6e249afa87b66e01fde6617">

            <tr>
              <td style="width: 47.41%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 4.58%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 48%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">TEGNA Inc.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 47.41%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 4.58%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 48%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 47.41%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 4.58%; vertical-align: top;">
                <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">By:</div>
              </td>
              <td style="width: 48%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 47.41%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Employee&#8217;s Signature or Acceptance by</div>
              </td>
              <td style="width: 4.58%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 48%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Jeffery Newman</div>
              </td>
            </tr>
            <tr>
              <td style="width: 47.41%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Electronic Signature</div>
              </td>
              <td style="width: 4.58%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 48%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Senior Vice President/Human Resources</div>
              </td>
            </tr>
            <tr>
              <td style="width: 47.41%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 4.58%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
              <td style="width: 48%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">PERFORMANCE SHARES</div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">TERMS AND CONDITIONS</div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">Under the</div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">TEGNA Inc.</div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">2020 Omnibus Incentive Compensation Plan</div>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">These Terms and Conditions, dated #GrantDate#, govern the right of the employee (the &#8220;Employee&#8221;) designated in the Award Agreement
          dated coincident with these Terms and Conditions to receive Performance Shares (referred to herein as &#8220;Performance Shares&#8221;).&#160; Generally, the Employee will not receive any Performance Shares unless the specified service and performance
          requirements set forth herein are satisfied.&#160; The Performance Shares are granted under, and are subject to, the TEGNA Inc. (the &#8220;Company&#8221;) 2020 Omnibus Incentive Compensation Plan (the &#8220;Plan&#8221;).&#160; Terms used herein that are defined in the Plan
          shall have the meanings ascribed to them in the Plan.&#160; If there is any inconsistency between these Terms and Conditions and the terms of the Plan, the Plan&#8217;s terms shall supersede and replace the conflicting terms herein.</div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">1.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Grant of Performance Shares</u></font>.&#160; Pursuant to the provisions of (i) the Plan, (ii) the
            individual Award Agreement governing the grant, and (iii) these Terms and Conditions, the Employee may be entitled to receive Performance Shares.&#160; Each Performance Share that becomes payable shall entitle the Employee to receive from the
            Company one share of the Company's common stock (&#8220;Common Stock&#8221;) upon the expiration of the Incentive Period, as defined in Section 2, except as provided in Section 13.&#160; The actual number of Performance Shares an Employee will receive will be
            calculated in the manner described in these Terms and Conditions, including Exhibit A, and may be different than the Target Number of Performance Shares set forth in the Award Agreement.</font></div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-2-</font></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%-%-%-->
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">2.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Incentive Period</u></font>.&#160; Except as otherwise provided in Section 13 below, the Incentive
            Period in respect of the Performance Shares shall commence on the Performance Period Commencement Date specified in the Award Agreement and end on the Performance Period End Date specified in the Award Agreement.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">3.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>No Dividend Equivalents</u></font>.&#160; No dividend equivalents shall be paid to the Employee
            with regard to the Performance Shares.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">4.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Delivery of Shares</u></font>.&#160; The Company shall deliver to the Employee a certificate or
            certificates, or at the election of the Company make an appropriate book-entry, for the number of shares of Common Stock equal to the number of Performance Shares that have been earned based on the Company&#8217;s performance during the Incentive
            Period as set forth in Exhibit A and satisfaction of the Terms and Conditions set forth herein, which number of shares shall be reduced by the value of all taxes withheld by reason of such delivery; provided that the amount that is withheld, or
            may be withheld at the Employee&#8217;s discretion, cannot exceed the amount of the taxes owed by the Employee using the maximum statutory tax rate in the Employee&#8217;s applicable jurisdiction(s).&#160; Except as provided in Sections 13 or 14, such delivery
            shall take place on the Performance Share Payment Date.&#160; An Employee shall have no further rights with regard to the Performance Shares once the underlying shares of Common Stock have been delivered.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">5.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Forfeiture and Cancellation of Right to Receive Performance Shares</u></font>.</font></div>
        <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Termination of Employment</u></font>.&#160; Except as provided in Sections 6, 13, and 14, an Employee&#8217;s right to receive Performance Shares shall automatically be cancelled upon the Employee&#8217;s termination of employment
            (as well as an event that results in the Employee&#8217;s employer ceasing to be a subsidiary of the Company) prior to the Performance Period End Date,&#160;</font></div>
        <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-3-</font></div>
      </div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">and in such event the Employee shall not be entitled to receive any shares of Common Stock in respect thereof.</div>
        <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Forfeiture of Performance Shares/Recovery of Common Stock</u></font>.&#160; Performance Shares granted under this Award Agreement are subject to the Company&#8217;s Recoupment Policy, dated as of February 26, 2013, as amended
            as of December 7, 2018, and which may be further amended from time-to-time with retroactive effect.&#160; In addition, the Company may assert any other remedies that may be available to the Company under applicable law, including, without
            limitation, those available under Section 304 of the Sarbanes-Oxley Act of 2002.</font></div>
        <div style="text-align: justify; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">6.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Death, Disability, Retirement</u></font>.&#160; Except as
            provided in Sections 13 or 14 below, in the event that the Employee&#8217;s employment terminates on or prior to the Performance Period End Date by reason of death, permanent disability (as determined under the Company&#8217;s Long Term Disability Plan),
            termination of employment after attaining age 65 (other than for &#8220;Cause&#8221;), or termination of employment after both attaining age 55 and completing at least 5 years of service (other than for &#8220;Cause&#8221;), the Employee (or in the case of the
            Employee's death, the Employee's estate or designated beneficiary) shall be entitled to receive at the Performance Share Payment Date the number of shares of Common Stock equal to the product of (i) the total number of shares in respect of such
            Performance Shares which the Employee would have been entitled to receive upon the expiration of the Incentive Period had the Employee's employment not terminated, and (ii) a fraction, the numerator of which shall be the number of full calendar
            months between the Performance Period Commencement Date and the date that employment terminated, and the denominator of which shall be the number of full calendar months from the Performance Period&#160;</font></div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-4-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Commencement Date to the Performance Period End Date.&#160; In the event the Employee is terminated for &#8220;Cause&#8221; all unpaid awards shall be forfeited.&#160;
          &#8220;Cause&#8221; shall mean a termination of the Employee&#8217;s employment following the occurrence of any of the following events, each of which shall constitute a &#8220;Cause&#8221; for such termination:</div>
        <div>
          <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(i)<font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"> &#160;</font>any material misappropriation
            of funds or property of the Company or its affiliate by the Employee;</div>
          <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(ii)<font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"> &#160;</font>unreasonable and persistent
            neglect or refusal by the Employee to perform his or her duties which is not remedied within thirty (30) days after receipt of written notice from the Company;</div>
          <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(iii)<font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"> &#160;</font>conviction, including a
            plea of guilty or of nolo contendere, of the Employee of a securities law violation or a felony;</div>
          <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(iv)<font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"> &#160;</font>material violation of the
            Company&#8217;s employment policies by the Employee; or</div>
          <div style="text-align: justify; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(v)<font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;"> &#160;</font>material harm to the Company<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font>(financial, competitive, reputational or otherwise) caused by the Employee&#8217;s gross negligence, intentional misconduct or knowing or reckless disregard of
            supervisory responsibility for a direct report who engaged in gross negligence or intentional misconduct.</div>
        </div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">The Committee, in its sole discretion, shall be responsible for making the determination whether an Employee&#8217;s termination is for
          &#8220;Cause&#8221;, and its decision shall be binding on all parties.</div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">7.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Non-Assignability</u></font>.&#160; Performance Shares may not be transferred, assigned, pledged
            or hypothecated, whether by operation of law or otherwise, nor may the Performance Shares be made subject to execution, attachment or similar process.</font></div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-5-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">8.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Rights as a Shareholder</u></font>.&#160; The Employee shall have no rights as a shareholder by
            reason of the Performance Shares.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">9.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Discretionary Plan; Employment</u></font>.&#160; The Plan is discretionary in nature and may be
            suspended or terminated by the Company at any time. With respect to the Plan, (a) each grant of Performance Shares is a one-time benefit which does not create any contractual or other right to receive future grants of Performance Shares, or
            benefits in lieu of Performance Shares; (b) all determinations with respect to any such future grants, including, but not limited to, the times when the Performance Shares shall be granted, the number of Performance Shares, and the Incentive
            Period, will be at the sole discretion of the Company; (c) the Employee&#8217;s participation in the Plan shall not create a right to further employment with the Employee&#8217;s employer and shall not interfere with the ability of the Employee&#8217;s employer
            to terminate the Employee&#8217;s employment relationship at any time with or without cause; (d) the Employee&#8217;s participation in the Plan is voluntary; (e) the Performance Shares are not part of normal and expected compensation for purposes of
            calculating any severance, resignation, redundancy, end of service payment, bonuses, long-service awards, pension or retirement benefits, or similar payments; and (f) the future value of the Performance Shares is unknown and cannot be predicted
            with certainty.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">10.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Effect of Plan and these Terms and Conditions</u></font>.&#160; The Plan is hereby incorporated by
            reference into these Terms and Conditions, and these Terms and Conditions are subject in all respects to the provisions of the Plan, including without limitation the authority of the Leadership Development and Compensation Committee of the
            Board of Directors of the Company (the &#8220;Committee&#8221;) in its sole discretion to adjust awards and to make interpretations&#160;</font></div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;<br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-6-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">and other determinations with respect to all matters relating to the applicable Award Agreements, these Terms and Conditions, the Plan and awards made
          pursuant thereto. These Terms and Conditions shall apply to the grant of Performance Shares made to the Employee on the date hereof and shall not apply to any future grants of Performance Shares made to the Employee.</div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">11.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Notices</u></font>.&#160; Notices hereunder shall be in writing and, if to the Company, shall be
            addressed to the Secretary of the Company at 8350 Broad Street, Suite 2000, Tysons, Virginia 22102, and, if to the Employee, shall be addressed to the Employee at his or her address as it appears on the Company's records.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">12.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Successors and Assigns</u></font>.&#160; The applicable Award Agreement and these Terms and
            Conditions shall be binding upon and inure to the benefit of the successors and assigns of the Company and, to the extent provided in Section 6 hereof, to the estate or designated beneficiary of the Employee.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">13.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Change in Control Provisions</u></font>.</font></div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Notwithstanding anything to the contrary in these Terms and Conditions, the following provisions shall apply to the right of an
          Employee to receive Performance Shares under the attached Award Agreement.</div>
        <div>
          <div style="text-align: left; text-indent: 81.6pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>(a)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 26.4pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Definitions</u></font>.</font></div>
        </div>
        <div>
          <div style="text-align: left; text-indent: 81.6pt; margin-bottom: 5.05pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">As used in Articles 2 and 14 of the Plan and in these Terms and Conditions, a &#8220;Change in Control&#8221; shall mean
            the first to occur of the following:</div>
        </div>
        <div style="text-align: left; text-indent: 122.4pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(i)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 21.6pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a
            &#8220;Person&#8221;) of beneficial ownership (within the meaning of Rule 13d&#8209;3 promulgated under the Exchange Act) of 20% or&#160;</font></div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-7-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">more of either (A) the then-outstanding shares of common stock of the Company (the &#8220;Outstanding Company Common Stock&#8221;) or (B) the combined voting power of
          the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the &#8220;Outstanding Company Voting Securities&#8221;); provided, however, that, for purposes of this Section, the following acquisitions shall
          not constitute a Change in Control:&#160; (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or one of its
          affiliates, or (iv) any acquisition pursuant to a transaction that complies with Sections 13(a)(iii)(A), 13(a)(iii)(B) and 13(a)(iii)(C);</div>
        <div style="text-align: left; text-indent: 122.4pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(ii)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 57.6pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">individuals who, as of the date hereof, constitute the Board (the &#8220;Incumbent Board&#8221;) cease for any reason to constitute at least a
            majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least a majority of the
            directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an
            actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board;</font></div>
        <div style="text-align: left; text-indent: 122.4pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(iii)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 57.6pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">consummation of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the
            Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any of its subsidiaries&#160;</font></div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-8-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(each, a &#8220;Business Combination&#8221;), in each case, unless, following such Business Combination, (A) all or substantially all of the individuals and entities
          that were the beneficial owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding
          shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation or entity resulting from such Business Combination
          (including, without limitation, a corporation or entity that, as a result of such transaction, owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries) in substantially the same
          proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (B) no Person (excluding any employee benefit plan (or
          related trust) of the Company or any corporation or entity resulting from such Business Combination) beneficially owns, directly or indirectly, 20% or more of, respectively, the then-outstanding shares of common stock of the corporation or entity
          resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation or entity, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a
          majority of the members of the board of directors of the corporation or entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board
          providing for such Business Combination; or</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-9-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; text-indent: 122.4pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">(iv)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 57.6pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;&#160; &#160; </font>(b)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Acceleration Provisions</u></font>.&#160; In the event of a Change in Control, the number of Performance Shares payable to an Employee shall be calculated in accordance with the Change in Control rules set forth in
            Exhibit A, subject to the vesting rules set forth below.</font></div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;&#160;&#160;&#160;&#160;</font>(i)&#160; In the event of the
          occurrence of a Change in Control in which the Performance Shares are not continued or assumed (i.e., the Performance Shares are not equitably converted into, or substituted for, a right to receive cash and/or equity of a successor entity or its
          affiliate), the Performance Shares that have not been cancelled shall become fully vested and shall be paid out to the Employee as soon as administratively practicable on or following the effective date of the Change in Control (but in no event
          later than 30 days after such event), provided that the Change in Control also constitutes a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company within the
          meaning of Section 409A of the Internal Revenue Code of 1986 (the &#8220;Code&#8221;) and the regulations and guidance issued thereunder (&#8220;Section 409A&#8221;), and such payout will not result in additional taxes under Section 409A.&#160; Otherwise, in the event of the
          occurrence of a Change in Control in which the Performance Shares are not continued or assumed, the vested Performance Shares shall be paid out at the earlier of the Employee&#8217;s termination of employment or the Performance Share Payment Date.</div>
        <div style="text-align: left; text-indent: 77.2pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font class="HorizontalTab" style="width: 9pt; font-size: 1px; display: inline-block;">&#160;</font>(ii) In the event of the occurrence of
          a Change in Control in which the Performance Shares are continued or assumed (i.e., the Performance Shares are equitably converted into, or substituted for, a right to receive cash and/or equity of a successor entity or its&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-10-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">affiliate), the Performance Shares shall not vest upon the Change in Control, provided that the Performance Shares that have not vested under the other
          provisions of this Award shall become fully vested in the event that the Employee has a &#8220;qualifying termination of employment&#8221; within two years following the date of the Change in Control.&#160; In the event of the occurrence of a Change in Control in
          which the Performance Shares are continued or assumed, vested Performance Shares shall be paid out to the Employee at the earlier of the Employee&#8217;s termination of employment or the Performance Share Payment Date.</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">A &#8220;qualifying termination of employment&#8221; shall occur if the Company involuntarily terminates the Employee without &#8220;Cause&#8221; or the
          Employee voluntarily terminates for &#8220;Good Reason&#8221;.&#160; For this purpose, &#8220;Cause&#8221; shall mean:</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 7.5%; text-align: center; vertical-align: top;">
                  <div style="font-size: 12pt;">&#8226;</div>
                </td>
                <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;">
                  <div>any material misappropriation of funds or property of the Company or its affiliate by the Employee;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.5%; font-size: 12pt; text-align: center; vertical-align: top;">
                  <div style="font-size: 12pt;">&#8226;</div>
                </td>
                <td style="width: 92%; font-size: 12pt; text-align: left; vertical-align: top;">
                  <div>unreasonable and persistent neglect or refusal by the Employee to perform his or her duties which is not remedied within thirty (30) days after receipt of written notice from the Company; or</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 7.5%; font-size: 12pt; text-align: center; vertical-align: top;">&#8226; <br>
                </td>
                <td rowspan="1" style="width: 92%; font-size: 12pt; text-align: left; vertical-align: top;"> conviction, including a plea of guilty or of nolo contendere, of the Employee of a securities law violation or a felony. </td>
              </tr>

          </table>
        </div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">For this purpose, &#8220;Good Reason&#8221; means the occurrence after a Change in Control of any of the following circumstances without the
          Employee&#8217;s express written consent, unless such circumstances are fully corrected within 90 days of the Notice of Termination described below:</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 7.5%; text-align: center; vertical-align: top;">
                  <div style="font-size: 12pt;">&#8226;</div>
                </td>
                <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;">
                  <div>the material diminution of the Employee&#8217;s duties, authorities or responsibilities from those in effect immediately prior to the Change in Control;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.5%; font-size: 12pt; text-align: center; vertical-align: top;">
                  <div style="font-size: 12pt;">&#8226;</div>
                </td>
                <td style="width: 92%; font-size: 12pt; text-align: left; vertical-align: top;">
                  <div>a reduction in the Employee&#8217;s base salary or target bonus opportunity as in effect on the date immediately prior to the Change in Control;</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 7.5%; font-size: 12pt; text-align: center; vertical-align: top;">&#8226; <br>
                </td>
                <td rowspan="1" style="width: 92%; font-size: 12pt; text-align: left; vertical-align: top;">
                  <div>failure to provide the Employee with an annual long-term incentive opportunity the grant date value of which is equivalent to or greater in value than Employee&#8217;s regular annual long-term incentive opportunity in effect on the date of
                    the Change of Control (counting only normal long-term incentive awards made as a part of the regular annual pay package, not special awards not made on a regular basis), calculated using widely recognized valuation methodologies by an
                    experienced compensation consultant at a nationally recognized firm;</div>
                </td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-11-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 7.5%; text-align: center; vertical-align: top;">
                  <div style="font-size: 12pt;">&#8226;</div>
                </td>
                <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;">
                  <div>the relocation of the Employee&#8217;s office from the location at which the Employee is principally employed immediately prior to the date of the Change in Control to a location 35 or more miles farther from the Employee&#8217;s residence
                    immediately prior to the Change in Control, or the Company&#8217;s requiring the Employee to be based anywhere other than the Company&#8217;s offices at such location, except for required travel on the Company&#8217;s business to an extent substantially
                    consistent with the Employee&#8217;s business travel obligations prior to the Change in Control; or</div>
                </td>
              </tr>
              <tr>
                <td style="width: 7.5%; font-size: 12pt; text-align: center; vertical-align: top;">
                  <div style="font-size: 12pt;">&#8226;</div>
                </td>
                <td style="width: 92%; font-size: 12pt; text-align: left; vertical-align: top;">
                  <div>the failure by the Company or its affiliate to pay any compensation or benefits due to the Employee.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Any termination by the Employee for Good Reason shall be communicated by a Notice of Termination that (x) indicates the specific
          termination provision in the Award Agreement relied upon, and (y) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Employee&#8217;s employment under the provision so
          indicated.&#160; Such notice must be provided to the Company within ninety (90) days after the event that created the &#8220;Good Reason&#8221;.</div>
        <div style="text-align: left; text-indent: 77.2pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(iii)&#160; If in connection with a Change in Control, the Performance Shares are assumed (i.e., the Performance Shares are equitably
          converted into, or substituted for, a right to receive cash and/or equity of a successor entity or its affiliate), the Performance Shares shall refer to the right to receive such cash and/or equity.&#160; An assumption of this Performance Share award
          must satisfy the following requirements:</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 7.5%; text-align: center; vertical-align: top;">
                  <div style="font-size: 12pt;">&#8226;</div>
                </td>
                <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;">
                  <div>The converted or substituted award must be a right to receive an amount of cash and/or equity that has a value, measured at the time of such conversion or substitution, that is equal to the value of this Award as of the date of the
                    Change in Control;</div>
                </td>
              </tr>

          </table>
          &#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-12-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div>
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

                <tr>
                  <td style="width: 7.5%; text-align: center; vertical-align: top;">
                    <div style="font-size: 12pt;">&#8226;</div>
                  </td>
                  <td style="width: 92%; text-align: left; vertical-align: top; font-size: 12pt;">
                    <div>Any equity payable in connection with a converted or substituted award must be publicly traded equity securities of the Company, a successor company or their direct or indirect parent company, and such equity issuable with respect
                      to a converted or substituted award must be covered by a registration statement filed with the Securities Exchange Commission that permits the immediate sale of such shares on a national exchange;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width: 7.5%; font-size: 12pt; text-align: center; vertical-align: top;">
                    <div style="font-size: 12pt;">&#8226;</div>
                  </td>
                  <td style="width: 92%; font-size: 12pt; text-align: left; vertical-align: top;">
                    <div>The vesting terms of any converted or substituted award must be substantially identical to the terms of this Award; and</div>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 7.5%; font-size: 12pt; text-align: center; vertical-align: top;">&#8226; <br>
                  </td>
                  <td rowspan="1" style="width: 92%; font-size: 12pt; text-align: left; vertical-align: top;">
                    <div>The other terms and conditions of any converted or substituted award must be no less favorable to the Employee than the terms of this Award are as of the date of the Change in Control (including the provisions that would apply in
                      the event of a subsequent Change in Control).</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div style="text-align: left; text-indent: 36.05pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">The determination of whether the conditions of this Section 13(b)(iii) are satisfied shall be made by the Committee, as constituted
          immediately before the Change in Control, in its sole discretion.</div>
        <div style="text-align: left; text-indent: 40.8pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(c)&#160; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Legal Fees.</u></font>&#160; The Company shall pay
          all legal fees, court costs, fees of experts and other costs and expenses when incurred by Employee in connection with any actual, threatened or contemplated litigation or legal, administrative or other proceedings involving the provisions of
          this Section 13, whether or not initiated by the Employee.&#160; The Company agrees to pay such amounts within 10 days following the Company&#8217;s receipt of an invoice from the Employee, provided that the Employee shall have submitted an invoice for such
          amounts at least 30 days before the end of the calendar year next following the calendar year in which such fees and disbursements were incurred.</div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">14.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Employment or Similar Agreements</u></font>.&#160; The provisions of Sections 1, 4, 5, 6 and 13 of
            these Terms and Conditions shall not be applied to or interpreted in a manner which would decrease the rights held by, or the payments owing to, an Employee under an employment agreement, termination benefits agreement or similar agreement with
            the Company that&#160;</font></div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-13-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">pre-exists the Grant Date and contains specific provisions applying to Plan awards in the case of any change in control or similar event or termination of
          employment, and if there is any conflict between the terms of such employment agreement, termination benefits agreement or similar agreement and the terms of Sections 1, 4, 5, 6 or 13, the employment agreement or termination benefits agreement
          shall control.</div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">15.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Grant Subject to Applicable Regulatory Approvals</u></font>.&#160; Any grant of Performance Shares
            under the Plan is specifically conditioned on, and subject to, any regulatory approvals required in the Employee&#8217;s country.&#160; These approvals cannot be assured.&#160; If necessary approvals for grant or payment are not obtained, the Performance
            Shares may be cancelled or rescinded, or they may expire, as determined by the Company in its sole and absolute discretion.</font></div>
        <div style="text-align: left; text-indent: 40.8pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">16.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Applicable Laws and Consent to Jurisdiction</u></font>.&#160; The validity, construction,
            interpretation and enforceability of this Agreement shall be determined and governed by the laws of the State of Delaware without giving effect to the principles of conflicts of law.&#160; For the purpose of litigating any dispute that arises under
            this Agreement, the parties hereby consent to exclusive jurisdiction in Virginia and agree that such litigation shall be conducted in the courts of Fairfax County, Virginia or the federal courts of the United States for the Eastern District of
            Virginia.</font></div>
        <div style="text-align: left; text-indent: 40.8pt; margin-bottom: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">17.</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 31.2pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Compliance with Section 409A</u></font>.&#160; This Award
            is intended to comply with the requirements of Section 409A so that no taxes under Section 409A are triggered, and shall be interpreted and administered in accordance with that intent (e.g., the definition of &#8220;termination of employment&#8221; (or
            similar term used herein) shall have the meaning ascribed to &#8220;separation from service&#8221; under Section 409A).&#160; If any provision of these Terms and Conditions would otherwise&#160;</font></div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;">-14-</font></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">conflict with or frustrate this intent, the provision shall not apply.&#160; Notwithstanding any provision in this Award Agreement to the
          contrary and solely to the extent required by Section 409A, if the Employee is a &#8220;specified employee&#8221; within the meaning of Code Section 409A and if delivery of shares is being made in connection with the Employee&#8217;s separation from service other
          than by reason of the Employee&#8217;s death, delivery of the shares shall be delayed until six months and one day after the Employee&#8217;s separation from service with the Company (or, if earlier than the end of the six-month period, the date of the
          Employee&#8217;s death).&#160; The Company shall not be responsible or liable for the consequences of any failure of the Award to avoid taxation under Section 409A.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;"><u>Exhibit A</u></div>
        <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">Performance Share Calculation</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Subject to the Employee&#8217;s satisfaction of the applicable service requirements, the potential number of Performance Shares that the Employee may be awarded
          is the sum of the following:</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div>
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(i)67% of the Employee&#8217;s Target Number of Performance Shares multiplied by the Applicable Percentage determined pursuant to the chart set forth below
            based on the Company&#8217;s Actual 2024-2025 Compensation Adjusted EBITDA versus the Company&#8217;s 2024-2025 Target Compensation Adjusted EBITDA; and</div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div>
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(ii)33% of the Employee&#8217;s Target Number of Performance Shares multiplied by the Applicable Percentage determined pursuant to the chart set forth below
            based on the Company&#8217;s Actual 2024-2025 FCF as a Percentage of Total Revenue versus the Company&#8217;s 2024-2025 Target FCF as a Percentage of Target Revenue.</div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z0bae44bd53a540b3a60af2637a81286e">

            <tr>
              <td colspan="3" style="width: 100%; vertical-align: top; background-color: #000000; border-bottom: #000000 2px solid;">
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Applicable Percentage Chart</div>
              </td>
            </tr>
            <tr>
              <td style="width: 28.87%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
              </td>
              <td style="width: 35.21%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Actual Versus Target&#160;</div>
              </td>
              <td style="width: 35.92%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Applicable Percentage</div>
              </td>
            </tr>
            <tr>
              <td style="width: 28.87%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Below Threshold</div>
              </td>
              <td style="width: 35.21%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Below 80%</div>
              </td>
              <td style="width: 35.92%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0% - No Award</div>
              </td>
            </tr>
            <tr>
              <td style="width: 28.87%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Threshold&#160;</div>
              </td>
              <td style="width: 35.21%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">80%&#160;</div>
              </td>
              <td style="width: 35.92%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">65%*</div>
              </td>
            </tr>
            <tr>
              <td style="width: 28.87%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Target&#160;</div>
              </td>
              <td style="width: 35.21%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">100%</div>
              </td>
              <td style="width: 35.92%; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">100%*</div>
              </td>
            </tr>
            <tr>
              <td style="width: 28.87%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Maximum</div>
              </td>
              <td style="width: 35.21%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">110%</div>
              </td>
              <td style="width: 35.92%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">200%*</div>
              </td>
            </tr>
            <tr>
              <td style="width: 28.87%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Above Maximum</div>
              </td>
              <td style="width: 35.21%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">More than 110%</div>
              </td>
              <td style="width: 35.92%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">200%&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">* </font>The Applicable Percentage is calculated using straight line
          interpolation between points.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Definitions</u></font>:</div>
        <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;2024 Target Compensation Adjusted EBITDA&#8221; means the target Compensation Adjusted EBITDA amount set by the Committee at its February [__], 2024 Committee
          meeting.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;2025 Target Compensation Adjusted EBITDA&#8221; means such amount set by the Committee, in its sole discretion, in the first 60 days of 2025.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;2024-2025 Target Compensation Adjusted EBITDA&#8221; means the sum of the 2024 Target Compensation Adjusted EBITDA and the 2025 Target Compensation Adjusted
          EBITDA.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;2024 Target Compensation Free Cash Flow as a Percentage of Target Revenue&#8221; means the target 2024 Compensation Free Cash Flow as a percentage of target
          revenue set by the Committee at its February [__], 2024 Committee meeting.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;2025 Target Compensation Free Cash Flow as a Percentage of Target Revenue&#8221; means the target 2025 Compensation Free Cash Flow as a percentage of target
          revenue set by the Committee, in its sole discretion, in the first 60 days of 2025.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;2024-2025 Target FCF as a Percentage of Target Revenue&#8221; means the average, weighted on the basis of the respective 2024 and 2025 target revenue amounts
          set by the Committee, of the 2024 Target Compensation Free Cash Flow as a Percentage of Target Revenue and the 2025 Target Compensation Free Cash Flow as a Percentage of Target Revenue.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;Actual 2024-2025 Compensation Adjusted EBITDA&#8221; means the Company&#8217;s aggregate Compensation Adjusted EBITDA for its 2024 and 2025 fiscal years.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;Actual 2024-2025 Compensation Free Cash Flow&#8221; means the Company&#8217;s aggregate Compensation Free Cash Flow for its 2024 and 2025 fiscal years.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;Actual 2024-2025 Compensation Total Revenue&#8221; means the Company&#8217;s aggregate Compensation Total Revenue for its 2024 and 2025 fiscal years.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;Actual 2024-2025 FCF as a Percentage of Total Revenue&#8221; means the Actual 2024-2025 Compensation Free Cash Flow divided by the Actual 2024-2025
          Compensation Total Revenue.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">Compensation Adjusted EBITDA&#8221; means net income from continuing operations
            before (1) interest expense, (2) income taxes, (3) equity income (losses) in unconsolidated investments, net, (4) other non-operating items, (5) severance expense, (6) facility consolidation charges, (7) impairment charges, (8) depreciation,
            (9) amortization, and (10) expense related to performance share long-term incentive awards and further adjusted to exclude unusual or non-recurring charges or credits to the extent and in the amount such items are separately reported or
            discussed in the audited financial statements and notes thereto or in management&#8217;s discussion and analysis of the financial statements in a period report filed with the Securities and Exchange Commission under the Exchange Act.</font></div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;Compensation Free Cash Flow&#8221; means &#8220;net cash flow from operating activities&#8221; less &#8220;purchase of property and equipment&#8221; as reported in the Consolidated
          Statements of Cash Flows and adjusted to exclude (1) voluntary pension contributions, (2) capital expenditures required either by government regulators or due to natural disasters offset by any reimbursements of such expenditures (e.g., from US
          Government or insurance company), and (3) the same adjustments made to Compensation Adjusted EBITDA other than income taxes and interest to the extent of their impact on Compensation Free Cash Flow.&#160; When calculating Compensation Free Cash Flow
          actual changes in working capital for the year will be disregarded to the extent that are greater than or less than the collars specified by the Committee from the target change in working capital.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#8220;Compensation Total Revenue&#8221; means &#8220;Total Operating Revenues&#8221; as reported in the Consolidated Statements of Income.&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">In its sole discretion, the Committee may make such modifications to the Company&#8217;s Compensation Adjusted EBITDA, Compensation Free Cash Flow and/or
          Compensation Total Revenue for any year as it deems appropriate to adjust for impacts so as to reflect the performance metric and not distort the calculation of the performance metric.</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">&#160;</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">The Committee has the sole discretionary authority to make the above calculations and its decisions are binding on all parties.</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;"><u>Change In Control</u></div>
        <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">In the event of a Change in Control, subject to the satisfaction of the applicable service requirements and rules set forth in
          Section 13 and provided that the Employee&#8217;s right to receive Performance Shares has not previously been cancelled or forfeited, the number of Performance Shares that may be awarded to an Employee is calculated, as follows:</div>
        <div>
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(i)If the Change in Control occurs in 2024 or 2025, the number of Performance Shares shall equal the Target Number of Performance Shares; and</div>
          <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">(ii)If the Change in Control occurs in 2026 or later, the number of Performance Shares shall equal the number earned based on actual performance in 2024
            and 2025 as determined by the Committee as constituted immediately prior to the Change in Control.</div>
        </div>
        <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
        <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Feb. 2024</div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tgna8k_ex10-2.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Wachtell Lipton Rosen & Katz
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div class="BRPFPageHeader" style="width: 100%;">
    <div style="text-align: right;"><font style="font-size: 12pt; font-weight: bold;">Exhibit 10.2</font><br>
    </div>
  </div>
  <div>
    <div style="text-align: center;"><img width="207" height="86" src="image00002.jpg"></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">June 17, 2024</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">David T. Lougee</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">c/o TEGNA Inc.</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">8350 Broad Street, Suite 2000</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Tysons, Virginia&#160; 22102-5151</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">Re:</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><u>Retirement and Advisory Services</u></font></div>
    <div><br>
    </div>
    <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Dear Dave:</div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">On behalf of TEGNA Inc. (the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Company</u></font>&#8221;)



      and its Board of Directors (the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Board</u></font>&#8221;), I want to thank you for your many years of service to the Company, during which you have demonstrated remarkable
      leadership and have made immeasurable contributions to the Company. We appreciate your willingness to provide continued support and expertise to the Company during an advisory period following your retirement as President and Chief Executive Officer.</div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">This letter agreement (this &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Agreement</u></font>&#8221;)



      memorializes our agreement regarding the terms of your retirement as President and Chief Executive Officer, effective as of the date your successor commences employment with the Company (the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Effective Date</u></font>&#8221;), which is currently expected to be August 12, 2024, and your services to the Company as an employee advisor during the period commencing on the Effective Date described below.</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2623c6a3632744a482bc004d13338758">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">1.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Retirement</font>.&#160; Effective
                as of and subject to the Effective Date, you hereby resign from your position as President and Chief Executive Officer of the Company and, except as provided in Section&#160;2, from all other positions you hold with the Company and its
                subsidiaries and affiliates, including as a member of the Board.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3c4bab4fc0684258a4cbfa4d8a9a3041">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">2.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Advisory Period</font>.&#160;
                Subject to the terms of this Agreement, you shall continue to serve as an employee of the Company in the position and with the title of Senior Advisor during the period commencing on the Effective Date through August 31, 2025 (the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Advisory Period</u></font>&#8221;), subject to earlier termination of the advisory services pursuant to Section 5 of this Agreement.&#160; During the Advisory Period, you
                shall assist with the transition of your duties as President and Chief Executive Officer to your successor and perform such other duties as may be reasonably assigned to you by the Board or the Company&#8217;s Chief Executive Officer from time to
                time; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>provided</u></font> that you shall have no authority to sign any document or extend credit on behalf of the Company or its subsidiaries or affiliates,
                hire or terminate the services of any employee or other service provider of the Company or its subsidiaries or affiliates or to otherwise bind the Company or its subsidiaries or affiliates in any way.&#160; During the Advisory Period, you shall
                devote adequate business time and attention as reasonably required by your duties and responsibilities hereunder to the performance of the duties and services contemplated by this Section&#160;2, and the parties do not expect you to experience a
                &#8220;separation from service&#8221; for purposes of Section 409A of the Internal Revenue Code (the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Code</u></font>&#8221;) until the expiration of the Advisory Period. During
                the Advisory Period, you shall be permitted to perform your duties and responsibilities hereunder on a remote basis, <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>provided</u></font> that, if requested by
                the Chief Executive Officer of the Company with reasonable advanced notice, you shall make yourself reasonably available to provide services in person from time to time.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0dccb8159ed94aa1965fa6447d52ae2a">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">3.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Compensation</font>.&#160; In
                consideration for your services under this Agreement, you shall be eligible for the following compensation and benefits:</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z843582b7c83a4bf4bfaa2c2ad198b837">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: normal;">a.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Base Salary</font>.&#160; During the
                Advisory Period, you shall be paid a base salary, payable bi-weekly, at an annual rate of $550,000.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfb47284074c64d6d9fb9a1b83b0dee62">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">b.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Outstanding Equity Awards and
                  Cash Retention Award</font>.&#160; Any equity awards that you hold as of the Effective Date and the cash retention award contemplated by the 2023 Cash Retention Award Agreement between you and the Company (collectively, the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Outstanding Awards</u></font>&#8221;) shall continue to vest during the Advisory Period.&#160; For the avoidance of doubt, you shall not be entitled to any additional grants
                of equity awards or cash retention awards following the Effective Date.&#160; Subject to Section 5 below, unless the Advisory Period is terminated for &#8220;Cause&#8221; (as defined in Section 5 below), you shall be deemed to have retired as of the end of
                the Advisory Period for purposes of any portion of the Outstanding Awards outstanding at such time.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd65b9c814c40481da098b4978a0e5a1a">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">c.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Prorated Annual Bonus</font>.&#160;
                Subject to your continued employment with the Company through the date annual bonuses are paid in respect of 2024, you shall be eligible for an annual bonus for 2024, based on actual performance, and prorated based on the period of your
                service in 2024 as President and Chief Executive Officer of the Company (the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Prorated Annual Bonus</u></font>&#8221;).&#160; For the avoidance of doubt, except as
                otherwise set forth in this Section&#160;3(c), you shall not be entitled to an annual bonus in respect of any period following the Effective Date.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zecd4b5cb789b45b0859c3e9f8d9f6221">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">d.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Welfare and Retirement Benefits</font>.&#160;



                During the Advisory Period, you shall remain a participant in the Company&#8217;s health and welfare benefit plans (excluding any severance plans) and retirement plans to the same extent, and at the same level of coverage, as you participated as
                of immediately prior to the Effective Date.&#160; Notwithstanding the foregoing, the Company reserves the right at any time to change or discontinue the Company&#8217;s benefit plans in the future; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>provided</u></font>, <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>however</u></font>, that any changes made with respect to your benefits shall only apply to the extent
                that you are treated no less favorably than any other participants in such benefit plans.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc205511f34144879814f13cf86831b28">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">e.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Other Benefits</font>. You
                shall be provided with legal and financial services through the tax filing season for 2027 (April 15, 2027), consistent with those provided to you as of the date hereof.&#160; The Company shall provide you with continued access to your current
                executive assistant during the Advisory Period (to the extent such individual remains employed with the Company) for technical and administrative support as you may reasonably request.&#160; You will continue to have access to Company email
                during your employment through the end of the Advisory Period.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z42a75cab43c84c7c8c1e862c95c7e659">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">4.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Restrictive Covenants</font>.&#160;
                You acknowledge and agree that all restrictive covenants applicable to you as of the Effective Date (the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Restrictive Covenants</u></font>&#8221;) shall continue to
                apply during the Advisory Period to the same extent as if you had remained President and Chief Executive Officer. Notwithstanding the foregoing or anything in the Restrictive Covenants to the contrary, during the Advisory Period, you may
                serve on civic or charitable boards or committees or otherwise engage in community service, charitable activities and public speaking engagements and engage in other outside business activities, including, subject to Board approval, serving
                as a director on the board of for-profit entities, so long as such activities do not significantly interfere with or significantly detract from the performance of your duties and responsibilities under this Agreement and such entities are
                not competitive with the Company or its subsidiaries.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">You agree that you will not make any statements, oral or written, that disparage the Company or any of its current or
      former directors or officers. Likewise, the Company agrees that it will not make, and will use reasonable efforts to ensure that current directors and officers of the Company do not make, any statements, oral or written, that disparage you.</div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd3e7a000b88846e3b248c80aa877ea38">

          <tr>
            <td style="width: 18pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">5.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Early Termination</font>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaeb15391667346c68f840f3aef89725c">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">a.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Notice</font>.&#160; Either you or
                the Company may terminate your employment as Senior Advisor (and therefore the Advisory Period) upon sixty (60) days&#8217; written notice; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>provided</u></font>, <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>however</u></font>, that such advance notice shall not be required in the event your employment is terminated for Cause (as defined below) or due to your death.&#160;
                For purposes of this Agreement, &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Cause</u></font>&#8221; shall have the meaning set forth in the TEGNA Inc. Executive Severance Plan.&#160; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;">You shall not be terminated for Cause absent a resolution terminating you for Cause approved in writing by a majority of the Board.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za7699a87770c4253a26cc66833930dd5">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">b.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Termination Without Cause</font>.&#160;



                If the Company terminates your employment with the Company without &#8220;Cause&#8221; (as defined above) and not due to your death or permanent disability prior to August 31, 2025, subject to your execution of a release of claims substantially in the
                form attached to the TEGNA Inc. Executive Severance Plan<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>(the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Release</u></font>&#8221;)<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>and compliance in all material respects with all post-termination obligations applicable to you
                (including all applicable Restrictive Covenants, <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>provided</u></font> that the Company shall provide you with written notice of any alleged noncompliance and a
                reasonable opportunity to cure, if curable), you shall remain entitled to all compensation and benefits contemplated by Section 3 to the same extent as if your employment had not terminated and continued until August 31, 2025, including,
                for the avoidance of doubt, continued vesting of all Outstanding Awards through August 31, 2025.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc4de8bfccc9e4b78aae92208ede27738">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">c.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Termination Due to Death or
                  Permanent Disability</font>.&#160; If your employment with the Company terminates as a result of your death or permanent disability (as determined under the Company&#8217;s Long Term Disability Plan) prior to August 31, 2025, subject to your (or
                your beneficiaries&#8217; or estate&#8217;s) execution of the Release and compliance in all material respects with all post-termination obligations applicable to you (including all applicable Restrictive Covenants, <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>provided</u></font> that the Company shall provide you with written notice of any alleged noncompliance and a reasonable opportunity to cure, if curable), you (or your beneficiaries or
                estate) shall be entitled to (i) the Prorated Annual Bonus and (ii) continued vesting of the cash and equity retention awards granted to you in August 2023 to the same extent as if your employment had not terminated and continued until
                August 31, 2025 (or any more favorable termination-related vesting contemplated by the existing terms of the applicable award agreement).</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb44bb3fc57214bd69fbe803b68c3b903">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold;">d.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Payment Timing</font>.&#160; The
                compensation and benefits contemplated by this Section 5 shall be paid or provided on the same schedule contemplated by Section 3, except as modified to comply with Section 409A of the Code or other applicable law; <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>provided</u></font> that, to the extent permitted by Section 409A of the Code, the Outstanding Awards shall accelerate and be settled as soon as reasonably practicable following your
                (or your beneficiaries&#8217; or estate&#8217;s) execution of the Release.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd8144189cdc9480aa7f98fe10f7fc853">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">6.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Full Settlement</font>.&#160; You
                acknowledge and agree that your retirement as President and Chief Executive Officer pursuant to the terms of this Agreement is voluntary and not at the request of the Company or the Board, and, except as expressly provided in this
                Agreement, you shall not be entitled to any compensation or benefits from the Company or its subsidiaries or affiliates as a result of or following your retirement as President and Chief Executive Officer, your services during the Advisory
                Period or the termination of your services at the end of the Advisory Period.&#160; For the avoidance of doubt, you shall remain entitled to any retirement and other benefits that are accrued and vested as of the date your employment with the
                Company terminates.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaafcecc9b4324887bf1b7d86611f1978">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">7.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Tax Withholding</font>.<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160; </font>All dollar amounts set forth herein are gross amounts and are subject to applicable tax withholding.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2742cdb3ebd94689a0319ac9c1b347bc">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">8.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Section 409A</font>.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc24ed9a5f30040d1a18516ec1715ec1c">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">a.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">It is intended that payments and benefits made or provided under this Agreement shall not result in penalty taxes or
                accelerated taxation pursuant to Section 409A of the Code and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith.&#160; To the extent that any provision hereof is modified in order to
                comply with Code Section 409A, such modification shall be made in good faith and agreed upon with you and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to you and the Company of the
                applicable provision without violating the provisions of Code Section 409A. Any payments that qualify for the &#8220;short-term deferral&#8221; exception, the separation pay exception or another exception under Section 409A of the Code shall be paid
                under the applicable exception.&#160; For purposes of the limitations on nonqualified deferred compensation under Section 409A of the Code, each payment of compensation under this Agreement shall be treated as a separate payment of
                compensation.&#160; All payments to be made upon a termination of services under this Agreement may only be made upon a &#8220;separation from service&#8221; under Section 409A of the Code to the extent necessary in order to avoid the imposition of penalty
                taxes on you pursuant to Section 409A of the Code.&#160; In no event may you, directly or indirectly, designate the calendar year of any payment under this Agreement, and to the extent required by Section 409A of the Code, any payment that may
                be paid in more than one taxable year (depending on the time that you execute a release of claims) shall be paid in the later taxable year.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5731c5e254774d53a33356aaeae3ed24">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">b.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Notwithstanding anything to the contrary in this Agreement, all reimbursements and in-kind benefits provided under this
                Agreement that are subject to Section 409A of the Code shall be made in accordance with the requirements of Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during
                your lifetime (or during a shorter period of time specified in this Agreement); (ii) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a calendar year may not affect the expenses eligible for
                reimbursement, or in-kind benefits to be provided, in any other calendar year; (iii) the reimbursement of an eligible expense shall be made no later than the last day of the calendar year following the year in which the expense is incurred;
                and (iv) the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za6f93e67916c4453b9ee853062d5b6ff">

          <tr>
            <td style="width: 54pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 36pt; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">c.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Notwithstanding any other provision of this Agreement to the contrary, if you are considered a &#8220;specified employee&#8221; for
                purposes of Section 409A of the Code (as determined in accordance with the methodology established by the Company and its affiliates as in effect on the applicable date), any payment that constitutes nonqualified deferred compensation
                within the meaning of Section 409A of the Code that is otherwise due to you under this Agreement during the six (6)-month period immediately following your separation from service (as determined in accordance with Section 409A of the Code)
                on account of your separation from service shall be accumulated and paid to you on the (1st) first business day of the seventh (7th) month following your separation from service (the &#8220;<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>Delayed Payment Date</u></font>&#8221;), to the extent necessary to prevent the imposition of tax penalties on you under Section 409A of the Code.&#160; If you die during the postponement period, the amounts and
                entitlements delayed on account of Section 409A of the Code shall be paid to the personal representative of your estate on the first to occur of the Delayed Payment Date or thirty (30) calendar days after the date of your death.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z250e9a443fad4eccbde6c71b9ab6072a">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">9.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Entire Agreement</font>.<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160; </font>This Agreement contains the entire agreement between you and the Company with respect to your retirement as President and Chief Executive
                Officer and your services during the Advisory Period, and supersedes any and all prior understandings or agreements, whether written or oral, with respect to such matters.&#160; This Agreement shall be governed by the laws of the State of
                Delaware, without reference to the choice of law rules that would cause the application of the law of any other jurisdiction.&#160; For the avoidance of doubt, nothing contained in this Agreement prohibits you or the Company from terminating
                your employment for any reason or no reason prior to the Effective Date, in which case this Agreement shall be null and void <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">ab initio</font>
                and the terms of your termination shall be governed by the plans and agreements applicable to you as of the date of such termination.&#160; Notwithstanding anything to the contrary in this Agreement, in the event of your death, the Company shall
                provide your estate (or beneficiaries) with any payments due to you under this Agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6a529dd944d147ef8a94473d8c2244c9">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">10.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Counterparts</font>.&#160; This
                Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same agreement.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z52164462113f411cadbbb0d4c75d5ebd">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">11.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Legal Fees</font>.<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>The Company agrees to pay the reasonable fees and expenses of your legal counsel arising in connection with the negotiation and execution of
                this Agreement and any agreements related thereto (not to exceed $35,000 in the aggregate).</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze002f5f7c2b84261983760d8d09911bd">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">12.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Indemnification; Directors&#8217; and
                  Officers&#8217; Insurance</font>. You shall be indemnified, advanced expenses, and held harmless by the Company in connection with the performance of your duties as Senior Advisor under this Agreement to the same extent as you are entitled in
                your capacity as President and Chief Executive Officer prior to the Effective Date.&#160; The Company shall cover you under directors&#8217; and officers&#8217; liability insurance to the same extent as other officers and directors of the Company, which
                coverage shall continue through the Advisory Period and shall survive for a period of at least six (6) years thereafter.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc17cd0a6aea84dcb8bf54dc140129ad6">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right; font-weight: normal;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;">13.</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: left; margin-bottom: 10pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Reporting and Messaging</font>.<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160; </font>The press release and Form 8-K announcing your retirement as President and Chief Executive Officer and transition to Senior Advisor will
                be subject to your prior review and comment.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-style: italic;">[Signature Page Follows]</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Please indicate your acceptance of the terms of this Agreement by signing where indicated below.</div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="text-align: left; margin-left: 216pt; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Very truly yours,</div>
    <div style="text-align: left; margin-left: 216pt; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">TEGNA Inc.</div>
    <div style="text-align: left; margin-left: 216pt; margin-bottom: 24pt; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">By: <font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>/s/ Howard D. Elias</u></font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt" class="TRGRRTFtoHTMLTab">&#160;</font><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name:&#160; Howard D. Elias<font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title:&#160; &#160; Chairman of the Board of Directors</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt; font-style: italic;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div style="text-align: center;">[Signature Page to Letter Agreement (Lougee)]<br>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">Acknowledged and agreed:</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 12pt; font-family: 'Times New Roman', Times, serif;"><u>/s/ David T. Lougee</u></font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 252pt" class="TRGRRTFtoHTMLTab">&#160;</font></div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 12pt;">David T. Lougee</div>
    <div><br>
    </div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
  </div>
  <div style="width: 100%;" class="BRPFPageFooter">
    <div style="text-align: center;"><font style="font-style: italic;">[Signature Page to Letter Agreement (Lougee)]</font><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>tgna8k_ex99-1.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Wachtell Lipton Rosen & Katz
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div class="BRPFPageHeader" style="width: 100%;">
    <div style="text-align: right;"><font style="font-size: 12pt; font-weight: bold;">Exhibit 99.1</font><br>
    </div>
  </div>
  <img width="175" border="0" height="32" src="tegna_logo.jpg"><br>
  <div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
      </font></div>
    <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;"> <br>
    </font>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">FOR IMMEDIATE RELEASE</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font>June 17, 2024</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">TEGNA Names Michael Steib to Succeed David Lougee as President, CEO and Director</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Board Also Appoints Two New Independent Directors</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tysons, Va. &#8211; TEGNA Inc. (NYSE: TGNA) today announced that Michael Steib, 48, will succeed David Lougee, 65, as President, CEO and a Director as of August 12,
      2024. At that time, Lougee will retire from these roles and become Senior Advisor.</div>
    <div style="background-color: #FEFEFE;">
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Steib is currently CEO of Artsy, the world&#8217;s largest online platform for
          discovering and collecting art, after serving as President and CEO of XO Group (NYSE: XOXO), parent company of The Knot. Previously, he spent 10 years in executive positions at NBCUniversal and Google launching, scaling, and acquiring
          advertising-supported businesses. Steib has a track record of developing high-performing teams that build industry-defining products and brands and deliver extraordinary shareholder returns. He is a published author and has hosted a podcast on
          leadership and professional development. Steib holds B.A. degrees in economics and international relations from the University of Pennsylvania.</font></div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chairman of the Board Howard Elias said, &#8220;Dave has had a great run at TEGNA. The Board and I deeply appreciate all he has done to build the company into an
        industry leader with a strong financial position and a commitment to the communities in which we operate, but we understand his desire to retire as CEO at this juncture. Over the past year, the Board has engaged in a thoughtful and comprehensive
        succession process to identify TEGNA&#8217;s future leadership. We are fortunate that Mike Steib will be Dave&#8217;s successor working with a top-notch team.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;Mike is a dynamic executive with technology and digital savvy, a passion for local journalism, deep advertising and media experience, a history of
        developing high performance teams, and a track record of successfully building businesses and driving business model transformation. We are confident he has the broad skill set that will be necessary to chart TEGNA&#8217;s future at a time of
        unprecedented change in our industry.&#8221;</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mike Steib said, &#8220;I believe deeply in the power of local news to connect our communities and strengthen our democracy. And I am excited about the many
        opportunities to leverage technology to enhance this service and generate substantial value for shareholders. With strong operations in more than 50 key markets across America, a history of exceptional journalism, strong cash flow, and a talented
        and passionate team, TEGNA is incredibly well positioned to seize this moment and build a bright future for local news and community in our country.&#8221;</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Dave Lougee said, &#8220;I am confident that Mike is the right CEO to take TEGNA into the future at a time of profound change in our industry, and I look forward
        to helping him in any way I can. I am very proud of all we have accomplished over the last seven years and have been fortunate to work with a terrific Board, superb management team, and dedicated employees.&#8221;</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">TEGNA Adds Two New Independent Directors</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">TEGNA&#8217;s Board of Directors, as part of its regular refreshment process, has appointed two new independent Directors, Catherine Dunleavy, a senior finance
        and media executive formerly President of Away, and Denmark West, who heads Market Intelligence and Strategic Engagements at X, The Moonshot Factory, a division of Alphabet. They will join the Board on July 1, 2024.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Catherine Dunleavy is the former President of the travel lifestyle brand Away. She joined Away as Chief Financial Officer in 2020 after three years at NIKE,
        most recently as Vice President and Chief Financial Officer, Global Operations, Technology and Vice President, Strategic Investments. She has extensive media experience from her 16 years at NBCUniversal, where she served in numerous roles,
        including Chief Financial Officer of the Cable Entertainment Group and Executive Vice President, Content Distribution. She began her career at General Electric in the Manufacturing Management Program and was selected for its highly competitive
        Corporate Audit Staff program where she completed five years of rotational assignments across GE&#8217;s global businesses. She has had previous public company board experience and is a qualified financial expert.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Denmark West leads Market Intelligence and Strategic Engagements at X, The Moonshot Factory, a division of Alphabet. He has extensive experience in the
        technology industry, expertise in corporate finance and operations, as well as public company board experience. He previously spent eight years as a General Partner at Connectivity Ventures and seven years at Viacom, including as President of
        Digital Media at BET Networks and Executive Vice President and Chief of Operations at MTV Networks (now Viacom Media Networks). Earlier in his career, he spent six years at Microsoft in strategy and corporate development roles.</div>
      <div><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Howard Elias said, &#8220;TEGNA is committed to good corporate governance, and we are always looking to refresh our Board with directors who have deep experience
        in the areas that are most relevant to our business. Catherine Dunleavy and Denmark West will augment our already considerable expertise on the Board with additional digital media and financial expertise. We welcome them to TEGNA.&#8221;</div>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">About TEGNA</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">TEGNA Inc. (NYSE: TGNA) is an innovative media company that serves the greater
        good of our communities. Across platforms, TEGNA tells empowering stories, conducts impactful investigations and delivers innovative marketing solutions. With 64 television stations in 51 U.S. markets, TEGNA is the largest owner of top 4 network
        affiliates in the top 25 markets among independent station groups, reaching approximately 39 percent of all television households nationwide. TEGNA also owns leading multicast networks True Crime Network and Quest. TEGNA offers innovative solutions
        to help businesses reach consumers across television, digital and over-the-top (OTT) platforms, including Premion</font>, TEGNA&#8217;s OTT advertising service. For more information, visit&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">www.TEGNA.com</font>.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"># # #</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">For media inquiries, contact:</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Anne Bentley<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font>Vice President, Chief Communications Officer</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">703-873-6366<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
        abentley@TEGNA.com</font></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">For investor inquiries, contact:</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="background-color: #FEFEFE; font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Julie Heskett</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font><font style="background-color: #FEFEFE; font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Senior Vice President, Chief Financial Officer</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font><font style="background-color: #FEFEFE; font-size: 10pt; font-family: 'Times New Roman', Times, serif;">703-873-6747</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font><font style="background-color: #FEFEFE; font-size: 10pt; font-family: 'Times New Roman', Times, serif;">investorrelations@TEGNA.com</font></div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>tgna-20240617.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<xs:schema targetNamespace="http://tegna.com/20240617" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:tgna="http://tegna.com/20240617" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="tgna-20240617_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tgna-20240617_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://tegna.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>tgna-20240617_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>tgna-20240617_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://tegna.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="tgna-20240617.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tegna.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $. IP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5&Z,54D _E0!HT5\U_\ #26O_P#0#TW_ +ZD_P :/^&DM?\ ^@'IO_?4G^-
M'TI17S7_ ,-):_\ ] /3/^^I/\:^B=+NVO\ 2+*\=0KW$"2LJ] 64' _.@"W
M1110 4444 %%<9\3?'#> O"ZZE!!%/=2SK##%*2%.<DDX] #7CW_  TEK_\
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M.O\ D0?$'_8/F_\ 0#705S_CK_D0?$'_ &#YO_0#0!\04444 %%%% !1110
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MK;Z18R2*6VO<,I$,?^\^,#^=?7O@70-0\,>$K+2=2U$7T]NNT.JX5%[(#C)
M]3S0!T=%%% %35/^01>_]<'_ /037P7WK[TU3_D$7O\ UP?_ -!-?!?>@ HH
MHH *^H/@)XU&M^&V\/7<I:^TQ?W1;.7@)XY]5)Q]-M?+];GA'Q+=>$?$]EK-
MIRT#_O$QP\9X9?Q&: /N.L'QM_R(FO\ _8/G_P#0#6IINH6VK:9;:A9R"2VN
M8UEC8'J",UE^-O\ D1-?_P"P?/\ ^@&@#X>HHHH *^[/#G_(L:3_ ->4/_H
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M\5^+]/T270[>W2[=E,JSLQ7"ENF/:@#K_ OPKTOP'JES?V-Y<SR3P^2RR@8
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M;\LY_"N6HH ^_P#J,BBN3^&GB$>)OA_I-^TGF7"Q"&X.>?,3Y3GW. ?QKK*
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M3_UY0_\ H KX3K[L\.?\BQI/_7E#_P"@"@#3HHHH CGGCMK:6XF;;'$A=V]
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MRG/TSG\*^U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#YQ_:4_Y#^A?]>LG_H0KPZO<?VE/^0_H7_7K)_Z
M$*\.H *<GWU^M-IR??7ZT ?>]I_QYP?]<U_E4U0VG_'G!_US7^534 %%%% !
M7/\ CK_D0?$'_8/F_P#0#705S_CK_D0?$'_8/F_] - 'Q!1110 5]"^&_@)H
M6L^&-*U2;4KU);RTBG=5"X!902!^=?/5>U:'^T)<:)H&GZ4OAN*5;.VCMQ(;
MLC?M4+G&SC.* .N_X9Q\/?\ 05OOR6C_ (9Q\/?]!6^_):P/^&F+K_H5H?\
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M2@#S_P 9_!6/P5X;N-8O?%$,FS"Q0"UVM,YZ*,O^)] #7DU=)XO\<ZYXVO\
M[1JUVS1(28;9.(X@?0#O[GFN;H ***MZ9IMUK&J6VG6432W-S((XT4<DF@#Z
M5_9WTAK+P-=:BZX-_=$IQU1!M'Z[J]?K,\.Z+;^'?#MAI%L (K2%8\@8W$#E
MOQ.3^-:= %35/^01>_\ 7!__ $$U\%]Z^]-4_P"01>_]<'_]!-?!?>@ HHHH
M ^V/ <4<_P ,_#\,J!XY-+A5U/0@Q@$5\J_$?P;+X)\7W.G8)LY/WUH^#@QD
M\#)ZD=#]/>OJWX??\DY\-_\ 8-@_] %<_P#&+P0/%_A"26U@WZK8 S6Q4?,Z
M_P 2?B.?J!0!\B44$$$@C!'444 %%%% !7W9X<_Y%C2?^O*'_P! %?"=?=GA
MS_D6-)_Z\H?_ $ 4 :=%%,FFCMX))YG"11J7=CT4 9)H ^:_VBO$'VWQ18Z'
M$V8["'S) "/]9)C^2@?G7B]:_BG6I/$7BG4]7D8L;JX=USV3/RC\%P/PK(H
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M=-U0M-&  !')GYT&.W((^N.U>95]L^/O"</C/PA>:2X43LOF6TC?P2K]TY[
M]#[$U\67=K/8WDUI<QF.>"1HY$/56!P1^= $-%%% !7W9X<_Y%C2?^O*'_T
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M_OJ/_P"(H'[-_AH'(UC5^/\ :C_^(KV:B@!L:"*)(P20JA03[4ZBB@ HHHH
M*I:QIL6LZ->Z9,[QQ7<#PNZ8W*&&"1GC/-7:* /&?^&;O#/_ $&-7_[ZC_\
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9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tegna_logo.jpg
<TEXT>
begin 644 tegna_logo.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" #  ^@# 2(  A$! Q$!_\0
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M!\309!P?W,G_ ,32?\+U^''_ $,T'_?F3_XFOB"?_CXD_P!X_P Z90!]Q?\
M"]?AQ_T,T'_?F3_XFC_A>OPX_P"AF@_[\R?_ !-?#M% 'W%_PO7X<?\ 0S0?
M]^9/_B:/^%Z_#C_H9H/^_,G_ ,37P[10!]Q?\+U^''_0S0?]^9/_ (FC_A>O
MPX_Z&:#_ +\R?_$U\.T4 ?<7_"]?AQ_T,T'_ 'YD_P#B:/\ A>OPX_Z&:#_O
MS)_\37P[10!]Q?\ "]?AQ_T,T'_?F3_XFC_A>OPX_P"AF@_[\R?_ !-?#M%
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M** "BBB@#X.^+O\ R6#Q-_U_O7&UV7Q=_P"2P>)O^O\ >N-H **** "BBB@
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MM2?)O(Q_'"WWOQ'4>XKD** /T>M;J&]LX;JUD66"9!)&ZG(92,@C\*EKP?\
M9F^(/]K>'Y?".I39N]-7S+0L>7@)Y7_@)/Y$>E>\4 %%%% !7QE^TC_R6F__
M .O:W_\ 18K[-KXR_:1_Y+3?_P#7M;_^BQ0!Y31110 4444 %>G?L\?\ELTG
M_KG/_P"BFKS&O3OV>/\ DMFD_P#7.?\ ]%-0!]JT444 %%%% !1110 4444
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M)U'_ )\+K_ORW^%']DZC_P ^%U_WY;_"OT7VK_='Y4;5_NC\J /SH_LK4?\
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M "BBB@ HHHH ^#OB[_R6#Q-_U_O7&UV7Q=_Y+!XF_P"O]ZXV@ HHHH ****
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M"WQK_P"2T>)?^OH?^@+0!PM%%% !1110 445L^'O#-[XE34QIJ[Y=/LFO&C
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M3_Y!-Y_UP?\ ]!-6JJZG_P @F\_ZX/\ ^@F@#\YV^\?K24K?>/UI* "BBB@
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MX_[C_KJW\Z_1F?\ X]I?]P_RK\YKS_C_ +C_ *ZM_.@"&BBB@ HHHH ****
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M*^(?^@#J?_@')_A1_P (KXA_Z .I_P#@')_A7Z&T4 ?GE_PBOB'_ * .I_\
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M **** "BBB@#X.^+O_)8/$W_ %_O7&UV7Q=_Y+!XF_Z_WKC: "BBB@ HHHH
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M&>WGOX8Y8GF)5U+@$&@#[2HHHH **** "OC#]H7P@?#'Q/N+N"/;9:P/M<1
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M_H5K3_OI_P#XJC_A2/PY_P"A6M/^^G_^*H ^&**^Y_\ A2/PY_Z%:T_[Z?\
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M9N\$Z\SS:8D^B7#<YM6W1Y_W&_H17E.N_LL^*K)F;0]1L-3C[*Y,+_D<C]:
M/#J*[?4O@W\0-*9OM/A>^=5_BMU$H_\ '2:YRY\,:]9L5NM%U"$CJ'M7']*
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M'5IM3UGP]:W5Y-CS)F+ O@8&<$=A5#_A27PY_P"A6M/^^G_^*H ^&**^Y_\
MA27PY_Z%:T_[Z?\ ^*H_X4E\.?\ H5K3_OI__BJ /ABBON?_ (4E\.?^A6M/
M^^G_ /BJ/^%)?#G_ *%:T_[Z?_XJ@#X8KT[]GC_DMFD_]<Y__135],_\*2^'
M/_0K6G_?3_\ Q5:&A_"_P9X;U:+4]#T&WL[V($),C-E<C!ZGT- '64444 %(
MS!5+,< #))[4M,GACN;>2"9=T<J%'7.,@C!% 'P1\2_$I\6_$?6=7#%HI;@I
M![1I\J_H,_C7+5]S_P#"DOAU_P!"M:?]]/\ _%4?\*2^'/\ T*UI_P!]/_\
M%4 ?#%%?<_\ PI+X<_\ 0K6G_?3_ /Q5'_"DOAS_ -"M:?\ ?3__ !5 'PQ1
M7W/_ ,*2^'/_ $*UI_WT_P#\51_PI+X<_P#0K6G_ 'T__P 50!\@_#3PV?%G
MQ'T;2"I:*6Y5YN.D:_,WZ C\:^^54*H51@ 8 ':N8\/_  V\(>%=4_M'P_H=
MO97>PQ^:A8D*>HY)]*ZB@ HHHH **** "BBB@ KF_B%X<7Q9\/M9T8KF2XMF
M\KCI(OS)_P"/ 5TE% 'YNNC1NR."K*<$'L:2ONNY^#7P^N[J6XN/#%H\LSEW
M;+C+$Y)Z^M1_\*2^'/\ T*UI_P!]/_\ %4 ?#%%?<_\ PI+X<_\ 0K6G_?3_
M /Q5'_"DOAS_ -"M:?\ ?3__ !5 'PQ17W/_ ,*2^'/_ $*UI_WT_P#\51_P
MI+X<_P#0K6G_ 'T__P 50!\T_L]>)O\ A'OBS9P2OMMM41K.3)XW'E#_ -]
B#\:*^FK?X-?#^TNHKFV\-6L4T+AXW5WRK Y!'S>M% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140272606331152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 17, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 17,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-6961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TEGNA INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000039899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-0442930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8350 Broad Street, Suite 2000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tysons<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">22102-5151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">873-6600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $1.00 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TGNA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M>]C\<,L9L+D!\/U:*?MVXC:RQ>\0XW\!4$L#!!0    ( .J)U%B?H!OPL0(
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M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( .J)U%@'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ ZHG46.YOS)#O    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ ZHG46)E<G",0!@  G"<  !,
M         ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #J
MB=183JYP3D\$  "3$   &               @($."   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ ZHG46)^@&_"Q @  X@P   T
M         ( !DPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #JB=18EXJ[
M',     3 @  "P              @ %O#P  7W)E;',O+G)E;'-02P$"% ,4
M    " #JB=18'#AEZC\!   \ @  #P              @ %8$   >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ ZHG46"0>FZ*M    ^ $  !H
M     ( !Q!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ ZHG46&60>9(9 0  SP,  !,              ( !J1(  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  \Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tgna8k61924.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tegna.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>tgna-20240617.xsd</File>
    <File>tgna-20240617_lab.xml</File>
    <File>tgna-20240617_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tgna8k61924.htm">tgna8k61924.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tgna8k61924.htm": {
   "nsprefix": "tgna",
   "nsuri": "http://tegna.com/20240617",
   "dts": {
    "schema": {
     "local": [
      "tgna-20240617.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tgna-20240617_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tgna-20240617_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tgna8k61924.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://tegna.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20240617to20240617",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tgna8k61924.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20240617to20240617",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tgna8k61924.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://tegna.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000898822-24-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000898822-24-000003-xbrl.zip
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M8V@/"4]018=:?%?!)LDF_UQ"\L2O[7BS.FITG7((24E.Y_D)P)6S_;AZUIV
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MD'E9Y@;H([P% $_EVC+JCNZ6\5I?R'VN,<?2EIA&N/@'A?RK#K^=S2KWR?5
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M;QQ5U[9<;Y.O$32%3-?3E*VN&#LNK:RWW7Q9(KI##&!-Y!:'L4@B:!T7++&
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MZ.[59*.:9*GY@<AGN5^2R@HOT+"2\^?-BJOPTOU&H"MK\F9+%"^UN,<HZ$@
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M/7%E"H\-BFY4%P6\$AZ6UQ/86#9-X'U97@4IO*_ %V;!'Z* !W8.< P87>\
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M:02GM4E"F,^CD!-8*6TM$6<7L;CL'!:D=XBB&+AT 5?^F]R\NLA3H@$0YI6
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M@T-OA)D7, *<%KFJK5*M'-1&YT>UJ$IU&,5$Q)FA#F4F1QBVT_$+]=Y3#)W
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MY.PS;$2:R=-@<^SOZ#5XTA?V3%R[=@=2+^K 0!A=]@:07PR"511H(M9H&-O
M$QB+$CTZ6-U0Y&5IOD+.R,*[J^YQ@(I]9=_Z/9_%!Z4,N0?R5:?ELN.M5]2B
M,:2"0)QBAU8)B#A4<#!C:]-1:X8@\N"(6,&B;+AS53"=>;4!ESC;1+O\R"4+
MG$(Y[#@+3+&GL?C&K [SBDFZ^@X:YF#LO#6)QO2Z*U%0^C%Q+XHQ"Q3+1M4S
M:II*_^O@5AX[#:XDFJQ%75W /H0F]1'=RIF2W>.D++QM14>*^P4PUZ1V,YD
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MD6Q0S.8IRWH\T7I8#APF4F6P*@^40:BX'#8PF7'^ZBGO"MF7V7^JMBNKSDX
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M6SF_R"G)W:9ZKI6])VI=A,"UFI)@W1=NCB3XF!<CF5 2&C$9[M-C?"U?*;X
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M?CV#?LT$!#,"2'$Q=)^Z]#0Q8&8H:*I\"X5/GW10Q7 PGZF>W"RKBURU310
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M=*<L=EJA:Z7G$94>00#6N@"FFPZ&F/ )*@_A7,$YBN)<5@QJ'>03C!S5&3J
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M!_M/DM+A4QEA!]7515Y0I\J<28QL"LI==#99J1C8X!H$K )?QI;9"6,8H=%
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M6)\/^(NG[+YWAI'<UI9 KT)E'22R\[,< 6L)9EVUI1.%"@79W2:B I,%9!+
MPJ@0L:QP^S<^'?NDP9/H3VD)<^1^(\O[LU^"HD3\U%M2T(CU)B25:&N=[4*O
MG7& Z'GV%)E;::&7YFJT*_0[A&#=[SF$5*RZXML[G@+%^3X78G&95W@(Q;\W
MR(,0PU?D-\%=0PI1!4M@5#MKGQ;P#6!AC!NT=5HR]/24:U#(9 CTTH>H-FZR
M6)T1C6UX*#C8S[6-W7R_7@6$7%P"\A_120 $Z.J#7+-OS0L:(<YA<U7:SJ7)
M(P*AFT>BO<YXGPT:)4L!8RATHJ.CZ="01BXQ "< =+5!##CYX_E+,XMW&#O*
M>,H^BDN!PN)U'HL']CK&0[8_V\"JI403S%T6+=#M;)%'>OL,8,2-^PFA:XWG
MI]+^!(-U>VP(W%CH&L1M&'+ Y-%7@R30\!/:QZ)4^VMX_G>T8$B2U >$!!MN
M[Q@W(SQOLVW%/RMW4BG2I 7^EURF]&W+;UF?!CCUP.#2[$X-[/3WT1#9TQ 9
MQU$4!LYD+N*YS[DSGTX2/O7]63QQN7#Y=V^(>$=#Y$!#! %!9"4!;L<-\R[K
M0TR$P A(J.6.";O4IU[+S9UF"6"P )Y)/)N)5A";"$5D$4-0'(I,)*!>/#DB
MQGZ($?C>)'##611XW \3^#_G;N3RV)D'8>#-O@0Q)OX>B''@(<(?OB2"="->
M[$ Q?@21 T'D%0?+X!-/>;'M8$BCZ?>QY!95C4O0YU'+ J6"AA[!9ULZHZ$$
M"L3G%#[B%04]LVP#:BR&;E'3^=-D,A[!&3DJ&GO"1A+Z,S?PQS,_FOKQ-)XG
MX9P[ !CA.!9BZGXUV+A/1>-!L>3D17B$C0-AX^=-558@YA$A?@ #O=JREU>\
MB,D,Z^,%8Z]YN01;U=CX]' '<%ZB'T2-Q=58M3^'HBU-F+SCF#2&>83O*.IW
MT" #ICUFQ[G>($6-Y@,X5@%09?1ZWG&<G,+!3!4%"&0/:'3;?%8,'C+!^W[C
M2S U;1]OUQ#7+'^K]3A^F<O8.$GB?!.V-#_T<J#VEY$SF0QP"G8!1"+K +T7
M!<^&PEXP6GM%,9]A8)5*2Y/L+["AUG*E-_Y:BNB/0'M-R9W4GRMF)=3.MYA4
M5[U8K_FFK)TNI["]8M!8LU8PT+S@K"/B8MPEQ ER,JH$$'N+HCLQ3^[DZ.CY
M>Y"YF#=D.5+Z^X#EUD=P3,CM>S31#Y"<\702SJ/ \2-_[ =.S,>@:/OS6<#'
M8L*=+S+1OU7)&1TEYX&2\T.1JS3%ETKQ?95GFW*/("(9[4V*X4TY829@5V>6
M:5T[Q%>BQ[30NCK@'7I.\0V -RH]:[?AWRCM-!!]IKZ#&G],GM:HPM];WG?E
M/E^;R==/6@%('0X;"*3I4 B0254KA^9^/*1W?,>R]F3U721OG9XR(%#K:$XI
M*N0\+#G%?[OQ"N\T.KM5AK?7L;T+2 AU\U '9/-1VNPG;404^^$D"F?!//0G
MX3B8S"-/S), ++8I;)&CM.EC\AWSGX[2IB=M?A%I@C"/*&G5@KS2SMFNW+%S
MH9O_[A3SI;1[C!>K^&@DUYA:H7-3NHD$2\%30"[*5-$4:G\Q TLM*]DI8*#)
MB<LP9P-6D%"2?GVF@WWU?-27=,RWY"NA(OK52(>6F\]3&"E%?(MR''*!@DEE
M]-5D5Z3(#QHS6"\08V@\!7 L9%['F8<-EI_R"H5RK:8KEWDA%CG\-&K))D!>
M3/51%HPJU"3_V+8.OT5+GBTH02"696/K#7"WS4J]!,FFVA1?)P_C_B.KR_P*
M=T#K'>0<0 8IQI2JHD-'1Y48,^J2B47HG9IG& )=K].M63ZU6X:L->V P!U:
MZ<K;+&=D:R8@NPL*IV(U"Y&B,T6; T#L)].LM2A'J;FGU(S<\63B.(GG.[X?
MS.9@K26.%R7!-/"<T/VB7/9O56K>43<[2LV^=Y..<5=(LG_NSO(+19-*3A"4
MB@4HUBA]$IF!Y)+P4U/H8AEF%;]FF&\%XJ&D! UC3\W8Z4N0,2ES)I1H.0-]
MGF*X9659>WEIO5FG\G7JB3 ')D^,3+JPA(ZBW>1_X%=IU,:ZY)1@V)B=JKBG
MSP11FUXJW1%%_V[O(QAB-NPJ?)0@(H$,B@61)F'JG40_S_Y,!:!%M,QP?RHA
M'Z]D)JD&$.FH2^^4<,?\QTY2F2CKU,Y_TLP[+E1R[#4,,#Q#VH82W-1LB4V6
M36ZOM'()#KICC^)@/W'@NWPVB7CH>U'@1[,HB!P13-UH/HEF8CJ9?_=9-?X1
M^P\N;0(,D4J7?PTV0H9:W&W^.000'GW.\JM48#,5 B0,)6DME<RC9MS(C$M:
M*+!99^*UP;L3Y7I([]6.2=\ATM3GA5*L;T#_OIF&DY:)+N>.-?X#[M^MQOEF
M,XLRFK-MM<1_:UMH<+J&+BH#IYR%W7,8&:$R[*P4Z-F,0)Q%%/!:\D(J] WS
M.@J6KRB=5:5<-VX]D2W *$5"\8E-AK$SK3>,[)$X4B_KQ-?U)H1]Q,#LX9^1
M9C4,BB#U^V989:)@\ AE?IV'W8QGU:.U:BM490#6P.>7/!TIJH9R>:F(+=:M
M!HR/-S0]"&!ASF$(-(7(&4EO+,&DRE7]&RD#UNQTEC6F[4M8;TZUQ1*SGQ/0
M:Y1J *]I_SX6L(1 MLI?[>>!WYHW/)0,IVL7@3Q#.)J%_?DCN90.AP]=BKY?
M?B#O_@$U@ <W0VZ%;$+'!@VW1MM"1E&*,NFB%8 <;=@1, B4.N#258%')-.V
M/O9AX>BRZ3*3_DJ(IUI#A4\-<W#9L12F;GV!>U(A1_F(O9>?!9Z[MC.&B-7I
M![)J$SO2]57PT:84=B*V2- ?3S@BLG)3Z.D:DAH*."F"BH1NC$)O=_.F_?@"
MG/U.:MMC3\PX/!4&0>!/A1>Z?A %8\Z#V4QP[XO\ 4[P#2B DZ,">* "^ ,O
M0()<-!6$1OD[&FG[G5$N0F?BS9WI=.;YTV@:)($_3CPNDF ^<R?1T6?7W]S'
M1.9#C^U/5/W4;4<A2=M%C2,?2"RP!2]ZB)H:S:X?AY?= NI3G118"#0UAHR$
M,[8!I1(TTVO0X4^GXS,6\VVIHS1&ANNJK6\M+J.T>%69IJ?83D2HRSJU2895
MC%6/[?W4/<K9:R7KJ?P\BHMM1.VJC 6OECOM];>=C+MNU<M#E5 B\7VSVBY7
M1EZL!,^4/[B5XB'L_G*-&?RICHU^2'EF=OZ]DO[/;AK)X*+PL*2C@M94GE(;
MM:807_E&[:?)D%0; ,\"/A%NL?T)_U45:W<:H!#'CC)X3QD\F\[GJ!3/QI'O
M3CSN3J-H.@T\;^Z-XWARE,''JH#[D\&6TLQ^ =&;;RJF,>\N>2;OVJ9P#3)E
M3R[T7"I7^FVW97;S$#!'I8\@E/4D!HH1K#3GF3+92TXN(2O;H]/]I.4B4V0J
M9%:YVPB&J<!"*$PY2;E<*;\/1L@D *KIWM)G!M6W\ZKBT5+4/M,["("'7N-6
MN]J']4D3XP:\T%]UBKA5T)N72F(Q9CA193WL3DFQ2DHU*=66I'!J7E;GK08T
M(1QLKEJ']?S]_84_M=J!8?^8YAN#;NNOU\:@=>!VA([;6JW)(X5'Q8(R9S*+
ME10DZ<_?\JCE%,-53G#,@-H4@GHI1*ICZ]E ^EDKP95"%3OJDGN%0:;BP[LQ
M0-&"(0Q6((Q8ZI#:+B9^KGIC]""C<; /GON=B<'-P%C?0\&-A&8Y4!ZRHUO3
MT8NQ;^:1'XL@3*(HF@L_G 6<BSG 72!BX<YF7^9I_%8UJ&-UR'UH4&^4<O)&
MZR5]J&#H:-"JRIM:5>FV@NC#5K]0I-&T*'@'0FV35DV@[$;-2*E7:@B"/!4Y
MZZ>EOL<('T[0(I94EK,]M*O3(49829Z1BJ<9+POV]J((BJ'BK*V?J6BPTM >
M6-)_9X)]?SE^:EJ2M%9R<.>K-3VS"I0LL7\JSVA&@R4Y1-RIA$<&A6E=1DQ!
M<U6ZVJM5I6K7)MT.-HK>ME17?,_:0W_RO?Z+.@2Z0C^D24IN?#1 ^#D8(32^
MF>E04;2XENJ75HM*8>]254]==T0_.ZH2>ZH2H>^'H9=$DYGK^&$\G2>A",9>
M. TB+YR/O6^]L\LMTG50(!Y+?PXN-.4*9N!)."8=K>!BR.5P=UO)KC=DDT[G
M%U043$:RSOXA,"S1D['1%VT,6EYV9^Y5'LM$*I0EV:([WPTU0Z3>AW7G3 NR
M4G[U]3J/CMK5)%;'0FN.7;)'N\K[=??8"*!.%*;+14AUGR3H,%4J[W7+7&/:
MDYY\^_J0 4?#H+P]0',Z"H)]LU<"Q_>=8![%T=S'K)59,@\2X8R361(%DR\2
M!-]$^O+TB/H'HO[;#:#&)\*(@>L9!BM8;DA</O1VFU9O[1O:GF. ]S)/0='E
MQ;;VRFN+1!=I##0^KL."H^Y]#N)Z#?25A(3-S0[XT@$]>JC+X8Y>-RW1F%L5
MA76&Z=V;*G=,;/CEEU_T-.HT<QQ(7>XS0.=C:X9V>J:WQ]-+<D,)RUX=A8:<
MM50$V[JM3HGSFM4JE;Z@HIQBHZVE2]53=^@*I0&/1Y\'?1?(49KM&V/F222B
M:![ZGNL'P2Q,G' 6!].IXR3.?':\9VAVE&:'ND/Y-062L?^;9<1\G0 @TZ][
M"8 5 T)S0/%5OL&2BB8S!Q/ T%,(L+0H<BRDT(^0)"V$[<"T78(PL:MF8D?,
MV1-SW)GO1G'HB3">^]-@SL>>,^?1/')"SY^%7Y1;^DU@3G#$G ,/OVVI'U._
M#VW7X(MXSB>)-Q[[X]CA3C!QIB)R9LX$_OQZJ=^_3T_GMYSG_8Z,.BS0RZ@E
M 2KM:^6*+-M.1>K78CL+!XON&K-,FTQT.T7&4XPE\>L= :+&;Q;C4\JJ&;KP
MJ>=&)(,2OI[39:_4WE69L"M^+5>;5<^[-QJF.!2J2G&-X2-S":HJZS1Q,LH>
M1RV@]LJV_(=U@QMB4(G4JE8.R.#:/8HEG86Z\6;8HVL<IS0[>]HCE:6M1HH4
MBVK:U?7(&5ODV ".2]VMB7P#L4ILIU%->USZXBY>V0Y*T)&PD^"(H058<9W9
MG,-QE=A)EC:.OC$YRK-\):.Z=8ZID.Y>8Y0,FW:6NM5PT"0*7LH\56G)5!YJ
M?D]F9(]3CZ@W<;V+:6'^O8&SE&SK?!USM<\2U$(*"F/.H2@*GIH\1.6E@#&5
MS]>Z! A&;GZK*AJ5[=M\J,[&SEW;\L#W6=$$Y2VFU(/;MGL[*UZP5,(NUR'M
M',._F9HX;CTU01&WO2,W4SIB@L.FT[Q4C;AZ7]YUH$P')O*@:/X):ZR;0QIU
MGVF,;]=KF=>[G38U[_I!;KP?@ZI&J)U49Y"[7?1TRZ*VPPF9P%8DZ">SCKSR
ML]!C<E7?  B#:(@<J'E1F*D:6]\%$9L[1;#SE:K3P&G#]T>ZJ#55;J_,_#3"
M&Y=!T)C;SD!.@30 ^PFO=Z^;2^IE&[YWA YY:_[V16"[=Y<],IW3P2+]L&E\
MNE+5.QRXEI%=1F>#"#V-!; QMFY$5+W83!&SBH>(H23?LTY,3,,<AKR*UDN.
MJN6>JN5DYCG11+@3?S;SXXG'/<^;3#D77'@B=OWO7K7\=LL7NGT^ZK8>G<X=
M=4=<&T_(ZRQ7(5Z&UBBC0.-G:2NE \KH#9&#QB==]GO3[Q;21KE2:B;I@G5.
MGH8Y1>*.R_\4U%EM.JY0,;1D^Z@[E"(4,Z.4G]UB!&J3"=V!B9*2KG^CE@6Q
M#B+L2+<#'4 0')XVM\F"4$;U1Q162V=Z!C/G:G6UO31G3U4Z%BDGY#NC6P,,
M,:W.TRVZ1TKF[%B_44-36_J@Z*(@$W77T0)FX&5#B>FWOEUI$PT-TFX+V:*#
M9JVGW5X.$H\-*9JXSN;!'I1*EJ#D4J(%;WS@==E<>];M%L[T$=;=+66TM%F@
M3#>U_ -EDRIW[E)334U*8<8=\@?8 J-2#Y?FC*02MF9<A]- %57=31-+^=5?
M/TK(?>,QTV3NB>EL[DPCWY]XX5R(8.*-IVX\":=)\MU+R&\W/7U 0IJ>M+4%
MW _"]QI?Z5Y<*-?,K8%H==5638WFYMIBZ^;:/FK<=I6MNKFVG46^0SBN!%CO
M,9R%Q9:RD\)4ELLFA;7NWX.2'25\*^B. 6<%^EJ;MVQAC!J?#5@/./U*5AL<
MXG;;MS]WI%SK_J:J^R8NJ(Y#I=4/K*E0'#9 K4!_*:_9Z?3L? 7KN#02V.Y8
MW4DSV&&<WF$I=M%_UF= KKZMQ?J-[ZTE''QAL]JD=48T65":"7KI3IVR.F.)
M+$#HU3W,+.E7DIVZ9*>S:GG&%$?N.OT'K&E\(U*.#4U-;B8V]AN\TWZ7Z4_7
M]2H;O&_S8U!1V?VR,?%O]C&TJT3 G!?VCL("AS68Q2OM\*3.=XVBMN.R+YW5
MH3386,^XO0_NYL>R+O$NZ9JI0F!V#XRK>KR:#:7R%,W64)L";SZ';53? 3+$
M>97Y(@LL8O'&9XW*A'TZ #PJ[3.+]=V$5F.)HTZR9[QV,A9S[OM>PF-?1%$8
MBVDT<\(Y#Z?CV?$:Y!?S;U8G>?!^71DFC34B\3^3)'+1%LNH2U$/:Y4U1Q3R
M.]TM.'B!P1X9@7T\-CF9^/"M68)U@U/5[!*A5\34)5.I5:HX#*OU2+ 835/E
M.)H)EN21(+W3U(UA=GZ!;4.[\U,Q* X/%653G3#L_U_@G1U9H^^E_*H.5'Q2
M,F @!H#0?\6QY,P$?PI4W@2%X+3JN\QU51L\RHI-:KH_7N6;%'0\ZEACJ8QV
M$CQ^0[NTE:K]*W"UC&74#:WL2HM$<]<497&C<G74/%#?ES)$G5;ULFIM&96#
MVG3:V>&QL?(A$UTRI@)S.%Z6FQ]NN-=DU#@-(DX<&5ZG#).0*3L3@Q/W?A!I
MJ">@X0-X11A,#X$NU(+T61QV7+32D(DA=J1GYQY3EZC4L4_M.KRA;;/1%M2%
MC,TK=ET*LX\7L]4LJZ61M!N8TFP&++&FJK/6FD[S3@'(F2YPM2.>MU@A1W5H
M3W5HRB?N/([GOA\[_DPD 8=_SKPXB%S7]Z-C_WKGCA> '_6AGE[R&HTL4> E
M1&6OZN_F: ;ZQK'X0<4U20[54?;(&E8'\0& E#"0I74A+AKP69/0892&^N&*
M?P9]H,H72D%H/"P4@#5(316#_ @PAT9)76?J^U/7<;S$=YR(QV$8CF,_FDWB
MB0CC(\ X1X Y$&#>T]5&;X4HOZZI55M:_4;M.:50J5A:W74B$;J[?QW?,QJ3
MNIP)$:T4@%"@KNO+(0",,NV:JGW.F5CDE6R*HNTJV('TFOZ5 36A2I<RO1@H
M^P_;55 /B)S2L>#C/WF3$1QOH^KQ!7QS@=[I(P;NB8%B/':323*+W##PW:DS
M#[S9=!P'\7@^=YPC!KYPW",&'HA([\ *6F5UWNQ3]L;<[F#JYP==X[4SIG[L
M'=X4@0X!^Y8Y.X58OP>S"70_Y0;0E)=F*5+X@Q<KNI6R$PK; 6HWW8?2:W4]
M&'@:;G-CPH9U9:<<"(JIN^0X DRUW:.F^/8+5R^Z-K"ZYM4R7..!=:HOXS"?
MI=*TIY)F>7;,5]^F8R[SP,&LFT9:A<LCI?\.Y:BJFVA[ERM9=\=U[U"J4ZX9
MT'>);""7CI5WPRN&.8F5"0M2TD>II Z%-H[R9-^B%F<6Q6,^Y8('?AR%09A,
MX&_''SONG,?3HSSQCO+DX%OGL$.:<@?&[.\8[5W\QPI>+Z@B H5)8;7&>XL-
MB8/SO\$/&6C.T9>T*U!F/@"K#EY3UF1+YN %2X-YV]V&@$HJ%.)2PHQU"[\'
M=AD,[;U(H'>DO_L.]G%WU[?K]/Z_3Y1@C]=,?4#A\9:R&\I_[2(V@I4L<,&K
M94TE'*^;P+-&PU<?/[S%E[P"T?'Y)?S1G$G[%6MXY#S$9\Y)PL"I3J_XMMPQ
MD'VPGRTQ! $2+89Q]#]JN:!H>\+\]34;KZ\[H!Y2+<2Y_@QV\5+O;1<?[0 \
M"WGT>0%R-8O/N[^R.732NFG@[E>JT2>HM&4[4]CN84><O/B@SB667$1UPPLL
M>EM71J>[J>T**(ET81X<894Z; ;2UVGT;A%K+T5[,L"KL-B;4ZUD/]<98I7K
MWP>K_B$P;Z;8I%2R4I2CWR&-35_WWR%QK^!K]YT(];A\S'[,J:'DFT?L!U"X
M[>M&6V_#Z^U2#@/++)49 $R:1Y\[)XU0P2;+1@D@L0:@BX]__?CQXFV5_WCQ
M]_>@W'5\2_<[S; 1+76"%[[L+G_^!';&$RV6NXSZW1!Y@3:>H5+_]7K))1J6
MK>M;\(?:0KY'"34H&O>46K8PZ7WW;9X#AK8DU<T*0%\P@Z+R7F!Z@X6_I^_!
MLA/B[%\V^]OHV?OI>Q2T!TF6+\6[ETT_M-@J>GZR!W&'T'VO1D8-LF_XI8S9
MQ2.F=MQ#@:P[V0=EO]I2]F:_]S)U4"?8J>]8_SH,7&X%EH'M<8M-<#/TZ,6X
M82[/'H=YO*5_+*M5"O_X?U!+ P04    " #JB=18/^C7K'4-  #W+@  $0
M '1G;F$X:U]E>#DY+3$N:'1MW5IM<QNW$?[>F?X'5)XF\0Q)B[(MQ9+L*2W3
MMI+(<FW%23]UP#OP#O8=< %PI)E?WV<7./*HE[1-$UN-/&.=CCA@7Y]]=H_'
M9:BK)W_^DQ#'I9(Y7^$ZZ%"I)\?WXN]T\R_#H?A.9\IXE8M@#\4/,BN#JBK<
M;8(UXHWURH@OQ+<R_!R?X9]G-FMK98+(G)(!S[9>FT(\=5;F3N>%$J_?G,]U
MI<3>_='!:#QZ.-[?ZSU_8IN5TT49Q/C1HX=B*/9V]Q[T'Q\.HP;WD@K',YNO
MQ*S(;&7=XYT[<_[9$3ZL*O5X9VY-&,YEK:O5H?CR0M?*BU=J"?%K:;X<"+XS
M$%XY/3\2O-KKG]6A&.\VX4@$]3$,9:4+<R@J-<<=/N=0W-GEGZ.=*$VN%R*K
MI/>/=YZ^>?W\M2S42\BGW%J0I<Y#2=ON_C4]E!Y+G_=/8@-@U3')LZ5)DFV/
M9.,;2T5K#\7,5CF>F'XL]4P'\>C1:'Q\CU8\.9ZY[KA[."]9;WVEZT*P;(]W
MQ@</=["1@]B/=W9W1,E[/]ZYOP<M7$8R%D;^L[*%';UOBIWUUL?=;C>K%(WW
MOWGC%PRRV_RZW2^93VR,14:*]KO7T^[3G9]._R-8]?GY&W%Z=C9]=CJYF(HW
MT^^FD[?3SKJ_W=D[3Z[QWC>M46)\,& <V7(E75Z7&[^OM:\UT,7TQ:N)>"5I
MJS.=E5)5XFU0>@;D%6_;+%, TF=RH7/QG6T+I83TXK537N> VH$XF9X+:;!$
M.Y4%ZVZ-GKSYH= !.V?7Z_[42I>+2>6MF#2-U29X<;&T?-2IR56C#"FYULW?
M N7@L96W!@O>R9'XXL[7>^/QD8A>/#792'SUZA]OIX?B C?NPH>Y7,$_QK8F
MHVI:RK#MYH%X\/4 *(SJZJ_Q]D#L/QS<X'*Y-@PML',Q:8O6HWKN#;I,H,@?
MB4F(!P=H-NC"B(]T*F +,7>VQA+EE7"V@CUH^YG*;*W$6V4T3ICD"^VM&]UD
MYYG,/A0.:N;#KDP^G]*_=<6[XK)MI_T?(=W.DYBAVHNL=0Y.J5;L%?*!"WXU
M(&.*I755SA%R<.1%)5VAX!UK*@U<:BH9YM;5.-GU.)#(M<_L L> .9$78,P*
M/N8_'9POYT$YDF/!MWJ!P<N3%#^>BQ=P1M-%XX_G/Y[?'8A&.N9GMFZD6='"
M"\CYK;%A1/LLM&U]!>EQTS>T<KPK5DHZ+[01ZJ/*VJ 7D-UZ'3220""H7CT]
M^=[@KO.R8A%>6%N XU42(5]"2%@M@R?I@J,V^ZG5I%Y?:YEC@Z")+PY]"RQP
MQ!]G1""5]\J/$B:64%B*X!!LB-T,?(64R-5"5;8A@Y0 F&&C')F6_@Y*UCY&
M_ZS550Y%<N2(6PUS-=>&EC3.YFT64M [_!\O<U616M ;Y^$D;:1;"5_"AB7P
M"Y\@>UIG(-Q+1;$@1=/.*NU+B"[;4%)>8A^2N;2>%,(*FV>2HZ"O?L5\T9>Z
MX2<@T1QJP\(P:5*.B/7:"CC>BZ>CR0B?%DZIZ)_,&EOK+$H/,%7.R! W<:J2
MT6-=JHOD-!TX#EXK8_RJ6DBCY>@:]O.9D_>DE-IA*8E*PL?*\=(NZ=>TTC"Q
MESH?,"#O[1X!0E4TO"2K%]20"-<:"EC&ZA%'?MR&S'4*2ZH&:2R;!H&ET;\(
M"8 LXS:Y1<JB(,<8(@FZ'(*=+7;8>+,+L.14X&PH(0)N600;8DX:;%^MDRA!
M.?:K=>#V"1NF$^K68$UT[[)$V1!+)2S"&^(-($R@OP&Y\&/@4$,4YH #Q\(F
M<(?X7#&H".#S]TA+A*T:B7.*;CJIH8BD/!_TC$MJ*U.@FZ%@HJPK43C*,&^K
M!$PU+%6B2T0<;=3G(L:Q2V%,ER0* Y2>KZ+QUY@X;TF27OB/Q \0F"H2$* U
MY(54,C^H%/Q<MV:*JJ1:;Y1.1<8!=#]05B>S!]L, 6^P'"'!Z!:%=(I4UHS!
M(U\9[);U<)9U""HK#2IJL8JHI NB5 CWQ0)(+<EY;&U83%062"O>6Z 29/7U
M@*.ZCZZ\1ZUR+7$. DDK\!+:!J$!(D%8L/'E)5P5"5<1P"H":T+T*X"<W(%0
M049QSM >&SB/FCB]Z-\6M07DTE[&\S&4'>N  +C-8YE+*4F1.J/9@/ ?F#VI
MQ'*Z #&*9"#,1@""<;EP??3A$<G4:$OWUA .*#H1"8#'3:$H#V#;=8J/V(?C
MHUL45;U$V0+$4UBDTO!GAW-0A5/?+@$"<%D,':.6G*^P-LP76-L^#I'?H#EP
M 0]'8^2JMAG\OP+/9""5-4(KTUSO9K8-? ZD7VV,:[G"=YOBO J2.4!-/]IQ
M6YDR!AL!%W,>_$$R%,HP""+29@1]@1!U(:N6D:-?I%&=?Z T2O@;P9,K(2Q0
M6\< 8\3#7?%!K2"F^Z"("F3.(B(G->R<R>W\(.U4DPIK/]?2$:COI9A7=KG.
M#EEQ%&WTYR(?\Y8A#KDT2#V$)L$RAPR=P4M+FKIUE8*G<3 #_!TM4MNZXWVQ
M,$ED! _04FAO,($=FV";O;GJ@CD#9[^=L<Q%/'4KEX(9,;8!A$V%T!$6H@VH
MZ%$IE?@@V=:DTGI-YC/IHO;EAEP?))I06?N![$K,8^-0[%NJ*B%ES?42W&")
MWN\4\0 48Y$1XRLZIV60)'JQ)"R#EC*C<IJXH^WJ<D5UV2,U3&+AD4YB_4PI
MTZ^1ENO>NN@I!Y.BE' EAX5;1/V,<A I%BD&1UQDN3DBG))500"[ IF\=:'P
M"X.329[_%S.#SQS0V^4GTBP$PEI4;O0;*E2XJP%#3A4M^D;\GJ/+*]EUB54-
M8B\4QR:$#+ !DISB]:H-!N)$(J <-9[/6@.^%;F#C[U])*5J&Y\ZDM"1$2K)
MR@&3-@TGM;N(\1A(SY0A]$2]]FA3ER5EA(1SSAA2X1MZ@Z +XAN\_FT@ "\0
MI5-FF:0<-Y0_#IB;GUF =&F#>"Y)!Y87WM%,=NCDJBGE3 5F\JM8]=_;5-:2
M;8WXIH7$XS@"O$WL[ZH_.O"*=MZV,MV'N<#&1*71&I)4L55E!Z OQ )27L4;
MS/E+K>;B^;K?.)\#$10!&AEC-PT20HGVL4,7-/.GWTX'FSBHT;82K8L3#FSZ
MC@KPI8G#]><,Q(O*SNCO=<6%5;:Y[/9N@UY(G)H%M.20B,IQ-_(QQ&[C"H&-
M72T,*L;[/65ZDPF*2 7(]S3: )&(38UI86K;^CCU&O2;N*QJF;3>9,;DE1,Y
M@RNFU&P'J0UG:)R\D(+3=?9<5O4$$1%3%,5%HY-CKDN:SE0!/D*Z9" Q^ 5-
M7C#=J=#I(I_!2#KV=B9-.Y?4SI&H9QM\?^ULX5!Q2(@E-<>*GH32Q @(68C/
MPZ54== EAJT6[L0ZT#.J*Q/8(, M<L[UD;?<V)%+EN)=2<5H=]C%V=#-'8CC
M%":E=N14+Z9K!"QBA&R-><I-W]ZDB50<JV3KEGO&R=WS/L\[J(7ZJ462SC5+
MU#F,UX7;E/M]I.3>]U. Y,O+.=2S7XRF'IO9I.F&_D0[:L_+LW6(I-K!TMI>
MJN,L)J_RW[J/96O6T\<T>>1BW^4R^;;+@=>HCR:FQ4GL4J OZ.P[/ 52EWJ4
M/FD*R#Z)TP>]M-X:G/;[OF>IOSYCB,&S3Z<7\&X@?N5_,:E[: C+;V"/-CF[
M>+?9Y"MCETFD=$SWT=V1F$J'/HUAFBA^Q(#>1-;KCQN]SC3EE)T'6NYCK*P2
MS>\<U)L?1IB[3:EP\P1OW0W%P5B(S4]A;5^W@J@RQU_D(,LX*Y 5:J!GJLXS
M8-L1*&;TD1LP5<X[@A3YBDSM<2\X^R6!(1?[RS10IJ-2A43_*N/DCD[H &UT
M#>VZPI4B<Y%MP1ZBQV6%,W("9T.1Y;C$;-+/]BE.9/QYKA/@=N.A6"'IK,M(
MB"UXJ(+LY/<[V*LFP>-8]!KJ?PM>NEW; $QXN,!BWP(1?^,73#>]4*0R9Q"+
MQBYDV%"A#ELY+IG?1#+)@V_5>\'$"01XNC38&8E)K,[=:RG?S2.H('GJ#6E0
M1-E$8Q!-HB(\XWL3C;,SG@MKIFVZZ(!O\Q;%;\G,U8XWLQ53GVY*L_^ #E2I
M@/FP&=4\'(OO1V]'W82F-RZ)G7)ZN;8TB9O91CQ 0\2XVFMLP-XJ&N[[+I]I
MX=[#S>"GIA%.OXE*0@AZN=G@7%B47VOQFP+[4=?8#57K_B,:CV:)L%-OWU.D
M1&53\:U-?"6S1%Z/D@J2WG]#<,]<@':NVRIH?DUDNIIQX5J034>SBE0LV+I_
M;Z%UMY&=SR\9>FW>*Y.*_C"6-6*T(3J\)FH;^0=K6.$J#W<.8;HAF>ZK\XN+
MN_VHV918%,8:#Z>728-+PU<\MS673M.]D7@.ALIS.6W64^"!($'"%W?&^[M'
MOVF>+9?+440^9$,2]<H[[L\")W<$_MT"2:[_6@\YB9%'&WZ=FP A  @./YV-
M)N!_XBEUIVKU>W^;Z$H'QTSO)&)HEH J=8>?S@('N_>'7Q_<'^[?W]__W2P
MW)Q%(__M<J[<Y@"-U8@O/F.,;GGEYF_)W*#6?^ZP;UKT#6BE/.I8^$3?L/M4
MNJ7O(%V?@E=F,W\PY=<I?O#@X ^F6I>AZZ^G_#I\Z:Z.[]$7PODB?=W]7U!+
M 0(4 Q0    ( .J)U%BOX@1K0@,  # /   1              "  0    !T
M9VYA+3(P,C0P-C$W+GAS9%!+ 0(4 Q0    ( .J)U%BO#GX^?P@  '18   5
M              "  7$#  !T9VYA+3(P,C0P-C$W7VQA8BYX;6Q02P$"% ,4
M    " #JB=18/@[SF]H%  #K/@  %0              @ $C#   =&=N82TR
M,#(T,#8Q-U]P<F4N>&UL4$L! A0#%     @ ZHG46-8A#4[>&P  :9L   \
M             ( !,!(  '1G;F$X:S8Q.3(T+FAT;5!+ 0(4 Q0    ( .J)
MU%CVK#4IVFL  )KX @ 1              "  3LN  !T9VYA.&M?97@Q,"TQ
M+FAT;5!+ 0(4 Q0    ( .J)U%C":YYO:A\  .O"   1              "
M 42:  !T9VYA.&M?97@Q,"TR+FAT;5!+ 0(4 Q0    ( .J)U%@_Z->L=0T
M /<N   1              "  =VY  !T9VYA.&M?97@Y.2TQ+FAT;5!+!08
1    !P ' +\!  "!QP     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>tgna8k61924_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tgna-20240617.xsd" xlink:type="simple"/>
    <context id="c20240617to20240617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000039899</identifier>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20240617to20240617"
      id="Fact_95c5785cf8274231bcc5b934ec170bc8">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20240617to20240617"
      id="Fact_508c478a996c4f8aa3446ee8aa1b0652">0000039899</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20240617to20240617"
      id="Fact_fb96e28f72374e1ab7ae97f11f073f23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20240617to20240617"
      id="Fact_0f10313e758f4117926cd9eb2a114d94">2024-06-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20240617to20240617"
      id="Fact_506a9dcd93164215bc095a9ec82ccab0">TEGNA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20240617to20240617"
      id="Fact_a964d12c33624433861ca12bd88eb027">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20240617to20240617"
      id="Fact_dc834b54e9364eccb647ab11db7ec86b">1-6961</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20240617to20240617"
      id="Fact_7d7fd247edaa4e749176eb55a25f1104">16-0442930</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20240617to20240617"
      id="Fact_3db680a68c244561bad626520b47b8a3">8350 Broad Street, Suite 2000</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20240617to20240617"
      id="Fact_f22d7b9e66264d5db43c258c97c97ca5">Tysons</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20240617to20240617"
      id="Fact_d959b2d206e4494cb17483c558e04fbd">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20240617to20240617"
      id="Fact_9a6cf583069e49c3b024b60a3edaed39">22102-5151</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20240617to20240617"
      id="Fact_d7828581d4b14aac891f6d9fd231cf71">703</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20240617to20240617"
      id="Fact_6e41d238108549b8b82a844f213c5feb">873-6600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20240617to20240617"
      id="Fact_cb0989957ef244f681a2225b165dd82f">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20240617to20240617"
      id="Fact_175ca9522f61446b9444049b1f05b723">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20240617to20240617"
      id="Fact_c982b475933243cab0c063dc3e59102f">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20240617to20240617"
      id="Fact_8359b8563a69480d83b00829a8811315">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20240617to20240617"
      id="Fact_5e31ceded3774c8ba23649732e379acc">Common Stock, par value $1.00 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240617to20240617"
      id="Fact_2064d799a15548589e1f3ad9e109b0f3">TGNA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20240617to20240617"
      id="Fact_b0354103396f4afd9b37dc1aefd24d20">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20240617to20240617"
      id="Fact_5bda2c56866e4d05b8328b57e94400d1">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
